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THESIS OVERVIEW 
 
This thesis is submitted in partial fulfilment of the requirement for the Degree of Doctor of Clinical 
Psychology at the School of Psychology, University of Birmingham. It comprises two research papers, 
a public dissemination document, and five clinical practice reports.   
 
Volume 1 of the thesis contains the research component. Paper one is a systematic review of 
longitudinal studies looking at the association between depression and diabetes complications. Paper 
two describes a prospective longitudinal study, examining risk factors for postnatal depression in 
women with gestational diabetes. Paper three is a public dissemination document, providing a lay 
summary of the study described in detail in paper two. 
 
Volume 2 of the thesis contains clinical practice reports (CPRs). The reports reflect work conducted 
during clinical placements, as follows: 1) psychological models CPR (A cognitive-behavioural and 
psychodynamic formulation of Samuel, a 28-year old man with phobia of falling following an 
acquired brain injury); 2) service-related CPR (Adherence to initial goal planning meeting clinical 
standard in an outpatient brain injury rehabilitation service. Factors acting as barriers and facilitators); 
3) single-case experimental design CPR (Cognitive behavioural intervention in the case of Alice, a 15-
year old White British female with obsessive-compulsive symptoms); 4) case study CPR (The case of 
Monique, a 55-year old White British female with mild learning disabilities presenting with 
challenging behaviour.  A behavioural approach to formulation and intervention); 5) case-study CPR – 
abstract (The case of Martin, a 67-year old White British male presenting with hypochondriasis. A 
cognitive behavioural approach to formulation and intervention). Names and other identifying 
materials in all the reports were changed in order to protect confidentiality. 
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ABSTRACT 
Aims A meta-analysis conducted by de Groot et al in 2001 examined the magnitude and 
consistency of the relationship between depression and diabetes complications. However, all 
studies included were cross-sectional, and therefore no causality could be established. The 
current study aims to update and further examine the relationship between depression and 
diabetes complications by focusing on longitudinal studies. 
Methods Medline, PsycINFO and Embase databases were searched for articles published in 
English language journals between 2000 and 2011. All studies that investigated the 
relationship between depression and diabetes micro- and macrovascular complications were 
included. Quality assessment of included studies was also conducted.   
Results Ten prospective longitudinal studies met the inclusion criteria and were incorporated 
in the current review. Eight studies examined the relationship between baseline depression 
and incident micro- and macrovascular diabetes complications. Two studies examined the 
association between baseline diabetes complications and higher risk of depression at follow-
up. Only one study had good methodological quality. 
Conclusions The relationship between depression and diabetes complications appears to be 
bidirectional. The underlying mechanisms remain unclear and warrant further research. 
 
Keywords: diabetes complications, depression, systematic review 
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INTRODUCTION 
1.1 Diabetes mellitus 
Diabetes mellitus is a metabolic disease characterised by high blood glucose levels, due to the 
body’s inability to produce sufficient insulin or to use insulin efficiently. Common risk factors 
include a first degree family member with diabetes, being overweight, high blood pressure, 
and ethnicity (i.e. people from a Black or Asian background). 
Diabetes prevalence 
In the UK, 2.6 million people have a diagnosis of diabetes, with a further 500,000 estimated 
to be unaware of their condition (Diabetes UK, 2010). The prevalence is predicted to increase 
to four million by 2025 (Diabetes UK, 2010). The cost of diabetes care in the UK is estimated 
at £1.3 billion, accounting for 9% of all hospital costs (Wanless, 2002).  
In the United States (US), diabetes affects 18.8 million people, with a further 7 million people 
estimated to live with undiagnosed diabetes (Centers for Disease Control and Prevention, 
2011). The risk of death for people with diabetes is twice that of people of similar age without 
diabetes; diabetes is the seventh leading cause of death in the US (Centers for Disease Control 
and Prevention, 2011). Diabetes costs were estimated at $174 billion in 2007, with an 
additional $58 billion in indirect costs, due to disability, work loss and premature mortality 
(Centers for Disease Control and Prevention, 2011).  
Diabetes complications 
Chronic complications of diabetes include microvascular (i.e. damage to small blood vessels) 
and macrovascular disease (i.e. damage to arteries).  
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Microvascular complications of diabetes include: a) diabetic retinopathy, where the blood 
vessels in the retina are affected; it can lead to vision impairment and blindness; b) diabetic 
neuropathy, consisting of decreased sensation in the extremities (usually starting with the 
feet) and vascular damage, which can lead to increase rates of foot ulcers and infection, and 
possibly necrosis and gangrene; it is the most common cause of amputation of toes and feet. 
Diabetic neuropathies are believed to result from diabetic microvascular injuries to small 
blood vessels supplying the nerves. Vascular and neural diseases are closely linked, as blood 
vessels rely on normal nerve function, and nerves depend on adequate blood flow; c) diabetic 
nephropathy, consisting of damage to the kidney which can lead to chronic renal failure and 
often requiring dialysis.  
Macrovascular complications of diabetes include: a) coronary artery disease, leading  to 
angina or myocardial infarction; b) diabetic myonecrosis or muscle ‘wasting’; c) peripheral 
vascular disease; d) stroke.  
1.2. Depression  
Depression is defined in the Diagnostic and Statistics Manual (American Psychiatric 
Association, 2000) by the presence of several symptoms in the last two weeks (five symptoms 
for major depression and three symptoms for minor depression), leading to significant 
distress and functional impairment (see Table 1 below). Dysthymic disorder, or dysthymia, is 
another type of depression, where depressive symptoms last a long time (over 2 years), but are 
less severe than those of major depression (APA, 2000). 
It is estimated that depression is the fourth leading cause of disability and disease in the 
world, likely to become the highest cause of disease burden in developed countries by 2020. 
Most depression prevalence data is based on self-report instruments, such as the Centre for 
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Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977) or the Patient Health 
Questionnaire – 9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001) for detecting depressive 
symptomatology. In the UK, depression is the most common psychiatric disorder, with a 
prevalence of 2.6% among 16 to 74 year old adults in the year 2000 (Singleton, Bumpstead, 
O’Brien, Lee, & Meltzer, 2001).  
It is estimated that 6% of adults experience depressive symptoms each year, with depression 
constituting the third most common reason for attending a general practice consultation. One 
in four women and one in ten men will require treatment for depression at some point in their 
lives (National Institute for Clinical Excellence guideline, 2009). 
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Table 1. Symptoms listed in the DSM-IV criteria for major depressive disorder (APA, 2000) 
and symptoms of depression measured using self-report instruments (i.e. Centre for 
Epidemiologic Studies – Depression Scale, Patient Health Questionnaire) 
DSM-IV criteria (at least 5 symptoms present nearly everyday for 2 weeks and causing 
significant distress and functional impairment) 
Depressed mood 
Markedly diminished interest or pleasure in all or almost all activities 
Significant weight loss/gain or decreased/increased appetite 
Insomnia or hypersomnia 
Psychomotor agitation or retardation 
Fatigue or loss of energy 
Feeling of worthlessness/guilt 
Diminished ability to concentrate/make decisions 
Recurrent thoughts of death or suicide 
Symptoms of depression measured using self-report instruments 
Feeling sad/depressed mood 
Inability to sleep 
Early waking 
Lack of interest/enjoyment 
Tiredness/lack of energy 
Loss of appetite 
Feelings of guilt/worthlessness 
Recurrent thoughts about death/suicide 
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1.3. Depression and diabetes 
The prevalence of depression is significantly higher among people living with diabetes than 
the general population (Ali, Stone, Peters, Davies, & Khunti, 2006; Das-Munshi, Stewart, 
Ismail, Bebbington, Jenkins, & Prince, 2007). People with diabetes are 60% more likely to 
suffer from depression than those in the general population (prevalence data, Ali et al., 2006). 
It is estimated that 18% of people with diabetes also suffer from co-morbid major depression 
(Ali et al., 2006).  After an episode of depression, patients with diabetes relapse more often 
than people in the general population (Lustman, Griffith, Freedland, & Clouse, 1997).  
People living with diabetes are required to self-manage their diabetes, including dietary 
requirements, exercise, and medication adherence in order to achieve optimum blood glucose 
levels and thus reducing the risk of developing complications. A diagnosis of diabetes and 
depression is associated with poorer communication with health care professionals (Katon, 
2003), greater disability in daily activities (Bruce, Davis, Starkstein, & Davis, 2005), 
decreased quality of life (Katon, 2008), nonadherence to treatment (Lin, Katon, Rutter, 
Simon, Ludman, von Korff et al., 2006), higher rates of diabetes complications (Piette, 
Richardson, & Valenstein 2004), higher health care costs (Egede & Ellis, 2010) and higher 
mortality rates (Egede & Ellis, 2010). Studies also report an increased risk of dementia in the 
presence of co-morbid diabetes and depression (Katon, Lin, Williams, Ciechanowski, 
Heckbert, Ludman et al., 2010). A qualitative meta-synthesis of patients experience of living 
with diabetes and depression (Gask, MacDonald, & Bower, 2011) showed that a diagnosis of 
diabetes is associated with a range of psychological emotions, including shock, despair, 
anxiety and fear, guilt, irritability, anger, ‘existential insecurity’, isolation, shame and feelings 
of dependence (Gask et al., 2011:242). However, when diabetes is suspected and is associated 
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with a range of unexplained symptoms, the diagnosis can be perceived as a ‘relief’. Changes 
in blood sugar levels can also influence mood, with poor metabolic control leading to an 
increase in depressive symptoms and a reduction in the effectiveness of antidepressant 
medication (Lustman & Clouse, 2005). Further, the impact of diabetes management on family 
life can be significant; the family’s reaction can function either as a buffer against depression 
or be a cause of distress (Gask et al., 2011). Distress and depression in people with diabetes 
were associated with a range of negative coping strategies, such as defensiveness, denial of 
vulnerability to depression and/or diabetes, intellectualisation and lying (Gask et al., 
2011:242). The synthesis identified a moderator between diabetes and distress and depression, 
namely the sense of self. A person who sees themselves as a ‘person with diabetes’ is able to 
keep separate their identity from their illness; a ‘diabetic’ incorporates the diabetes into their 
sense of self. This impacts on their perceived control over their illness, which in turn 
influences diabetes self-management (Gask et al., 2011:247).   
A systematic review and meta-analysis on the effectiveness of interventions for major 
depressive disorder in people with diabetes showed psychological and pharmacological 
interventions results in an improvement of depressive symptoms and additionally sometimes 
in diabetes self-management and blood glucose levels (van der Feltz-Cornelis, Nuyen, Stoop, 
Chan, Jacobson, Katon et al., 2010). 
The relationship between depression and diabetes is bidirectional (Golden, Lazo, Carnethon, 
Bertoni, Schreiner, Diez Roux et al., 2008; Mezuk, Eaton, Albrecht, & Golden, 2008; Renn, 
Feliciano, & Segal, 2011). Recent systematic reviews and meta-analyses demonstrated that 
diabetes increases the risk of developing depression by 24% (Nouwen, Winkley, Twisk, 
Lloyd, Peyrot, Ismail et al., 2010). The mechanisms behind the higher prevalence rates of 
depression in people living with diabetes are not yet fully explained. Some argue that 
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biochemical changes due to living with diabetes lead to depression, while others argue that 
depression occurs due to the burden of living with a chronic disease and related disabilities 
(Campayo, Gomez-Biel, & Lobo, 2011; Renn et al., 2011; Talbot & Nouwen, 2000).   
At the same time, people with depression have a 60% risk of developing type 2 diabetes 
(Mezuk et al., 2008). This relationship may be explained by lifestyles, i.e. a decline in health 
self care behaviours among people living with depression (Golden et al., 2008; Knol, 
Heerdink, Egberts, Geerlings, Gorter, Numans et al., 2007) or by biochemical changes linked 
with depression (Knol, Twisk, Beekman, Heine, Snoek, & Power, 2006).  
Depression and hyperglycaemia 
A meta-analysis conducted by Lustman and colleagues in 2000 underlined the association 
between depression and hyperglycaemia in patients with type 1 or type 2 diabetes (Lustman, 
Anderson, Freedland, de Groot, Carney, & Clouse, 2000). The effect size was 0.17 (small to 
moderate, 95%CI, 0.13-0.21). Richardson and colleagues (Richardson, Egede, Mueller, 
Echols, & Gebregziabher, 2008) also assessed the relationship between depression and 
glycaemic control in a 4-year longitudinal study and found that they were significantly 
associated. 
However, a meta-analysis conducted by Nouwen and colleagues (Nouwen, Nefs, Caramlau, 
Connock, Winkley, Lloyd et al., 2011) found no significant association between elevated 
blood glucose levels in people with impaired glucose metabolism (IGM) or undiagnosed 
diabetes (UDD) and depressive symptoms. The risk of depression was similar between IGM, 
UDD and normal glucose metabolism (NGM) subjects. However, it should be noted that all of 
the included studies used a cross-sectional design. At the same time, people with known type 
2 diabetes had a significantly higher risk of depression than people with IGM or UDD. The 
 19 
results could be regarded as supporting the ‘diabetes as psychological burden’ hypothesis. 
Depression is also higher in people with chronic conditions other than diabetes such as 
asthma, chronic pain, and heart disease, where blood glucose levels are not elevated 
(Moussavi, Chatterji, Verdes, Tandon, Patel, & Ustun, 2007). Another explanation might be 
that people with undiagnosed diabetes have significantly lower levels of diabetes 
complications (Dankner, Geulayov, Olmer, & Kaplan, 2009). For example, a study conducted 
by Pouwer and colleagues (Pouwer, Beekman, Nijpels, Dekker, Snoek, Kostense et al., 2003) 
showed that diabetes alone was not associated with depressive symptoms, but living with 
diabetes plus diabetes complications was linked with depressive symptoms.   
There is a well established link between the presence of hyperglycaemia and the risk of 
developing diabetes complications. Prospective studies showed an association between 
hyperglycaemia and the presence of microvascular complications (Genuth, 1995; Klein, 
1995), myocardial infarction (Klein, 1995; UKPDS Group, 1998), stroke (Lehto, Ronnemaa, 
Pyorala, & Laakso, 1996), and macrovascular mortality (Standl, Balletshofer, Dahl, 
Weichenbain, Stiegler, & Hormann, 1996). Lowering blood glucose levels was found to 
reduce the risk of developing retinopathy, neuropathy, and nephropathy in patients living with 
type 1 (Reichard, Nillson, & Rosenqvist, 1993) or type 2 diabetes (UKPDS Group, 1998).  
Depression and diabetes complications 
The presence of diabetes complications is associated with a higher prevalence of depression 
(Lustman & Clouse, 2005; van Steenbergen-Weijenburg, van Puffelen, Horn, Nuyen, van 
Dam, van Benthem et al., 2011). A meta-analysis conducted by de Groot and colleagues (de 
Groot, Anderson, Freedland, Clouse, & Lustman, 2001) examined the magnitude and 
consistency of the relationship between depression and diabetes complications. The authors 
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focused on microvascular complications (diabetic retinopathy, neuropathy, nephropathy or 
end stage renal disease), macrovascular complications (such as coronary artery disease), and 
sexual dysfunction. The authors reviewed 27 studies and found a significant and consistent 
relationship between depression and the diabetes complications under study. The association 
was positive, indicating that an increase in depressive symptoms was significantly associated 
with an increase in the severity and number of diabetes complications. Effect sizes ranged 
between 0.17 and 0.32, with an overall effect size of 0.25 (small to moderate) and were 
similar across type 1 and type 2 diabetes study samples. However, all included studies had a 
cross-sectional design, allowing the reporting of correlational findings, rather than the 
identification of specific directions and pathways.  
Aim of the review 
The current systematic review follows on from the de Groot et al. (2001) meta-analysis and 
aims to examine further the relationship between depression and diabetes complications in 
longitudinal studies. A quality appraisal of included studies was also conducted. 
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METHODS 
Search strategy 
Literature searches were conducted using Medline, PsycInfo and Embase databases.  
The authors of de Groot et al (2001) meta-analysis did not specify their search strategy. In 
order to ensure consistency, the Medline indexing of the meta-analysis was used as the 
starting point for the search strategy of the current systematic review. 
The search strategy for Medline is presented as an example: 
1 exp Diabetes Mellitus, Type 1/co, di, px [Complications, Diagnosis, Psychology]  
2 exp Diabetes Mellitus, Type 2/co, di, px [Complications, Diagnosis, Psychology]  
3 "diabet*".ti,ab.  
4 1 or 2 or 3  
5 exp Depressive Disorder/co, di, px [Complications, Diagnosis, Psychology] 
6 exp Depressive Disorder, Major/co, di, px [Complications, Diagnosis, Psychology]  
7 "depress*".ti,ab. 
8 5 or 6 or 7  
9 Diabetic Neuropathies/co, di, px [Complications, Diagnosis, Psychology]  
10 Diabetic Nephropathies/co, di, px [Complications, Diagnosis, Psychology]  
11 Diabetic Retinopathy/co, di, px [Complications, Diagnosis, Psychology]  
12 Diabetic Angiopathies/co, di, px [Complications, Diagnosis, Psychology]  
13 9 or 10 or 11 or 12  
14 ("diabetic neuropath*" or "diabetic nephropath*" or "diabetic retinopath*" or "diabetic 
angiopath*").ti,ab. 
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15 13 or 14  
16 exp Coronary Artery Disease/co, di, px [Complications, Diagnosis, Psychology]  
17 "coronary artery diseas*".ti,ab.  
18 16 or 17  
19 Peripheral Vascular Diseases/co, di, px [Complications, Diagnosis, Psychology]  
20 "peripheral vascular diseas*".ti,ab.  
21 19 or 20  
22 Stroke/co, di, px [Complications, Diagnosis, Psychology]  
23 "strok*".ti,ab.  
24 22 or 23  
25 Sexual Dysfunction, Physiological/co, di, px [Complications, Diagnosis, Psychology]  
26 "sexual dysfunction".ti,ab.  
27 25 or 26  
28 15 or 18 or 21 or 24 or 27  
29 4 and 8 and 28  
30 exp Cohort Studies/  
31 29 and 30  
32 limit 31 to (english language and humans and yr="2000 - 2011" and "all adult (19 plus 
years)")  
The search terms were adapted to meet the requirements of each database. All articles 
identified through the database searches were screened for potentially relevant references. 
Titles and/or abstracts were screened by two reviewers (IC and AN). Full texts papers were 
scrutinised to see if they fulfilled the inclusion criteria. Disagreement between the reviewers 
were solved by discussion between the two reviewers. 
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Inclusion/exclusion criteria 
Articles meeting the following criteria were included: a) studies involving human subjects; b) 
studies published in English language journals between 2000 and 2011 (the 2000 cut-off was 
chosen because studies up to the end of 1999 were included in a meta-analysis by de Groot et 
al., 2001 ); c) studies involving adult participants (over 18 years old); d) longitudinal studies; 
e) studies examining the relationship between depression and at least one complication of type 
1 or type 2 diabetes.  
Studies examining the relationship between diabetes complications and both lifetime and 
current depression were included. Studies were excluded if they focused on gestational 
diabetes, impaired glucose tolerance, or pre-diabetes.  
Data extraction 
One reviewer conducted the data extraction process. Data of interest included: 1) name of first 
author; 2) publication year; 3) country; 4) study design; 5) number of participants; 6) age; 7) 
gender; 8) diabetes type;  9) duration of diabetes; 9) length of follow up; 10) method of 
depression assessment; 11) method of diabetes assessment; 12) method of diabetes 
complications assessment; 13) study results.  
Method of depression assessment could be either a diagnosis of depression assessed by a 
diagnostic psychiatric interview or a self-report assessment of depressive symptoms using a 
questionnaire. Type of diabetes could be assessed either via self-report, testing of blood 
glucose levels, or extracted from medical records. Diabetes complications could be assessed 
either via self-report, or with the use of diagnostic tests, or extracted from medical records.  
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Quality assessment 
Quality assessment of included studies was conducted by one reviewer using criteria for 
cohort studies proposed by the Centre for Reviews and Dissemination, University of York 
(Centre for Reviews and Dissemination, 2009). Criteria include a) choice of outcome 
measures; b) adequate description of study population; c) control for confounding variables 
(age, gender, education, socioeconomic status – shown to be independent risk factors 
associated with major depressive disorder in people with diabetes, Egede & Zheng, 2003), d) 
description of follow-up numbers; e) description of dropout rates; f) comparison of drop-out 
rates on key variables; g) sufficient follow-up period; h) blinding of baseline assessment 
(diabetes diagnosis only).  
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RESULTS 
Search results 
The Medline search yielded 187 potential articles. PsycINFO identified 34 potential articles. 
Embase found 112 potential articles. The search of reference lists yielded another 2 potential 
papers. The search protocol is presented in Appendix 1. Twenty-four full text articles were 
retrieved for closer examination.  
Fourteen articles were excluded due to: a) no investigation of the relationship between 
depression and diabetes-related mortality (Lin, Heckbert, Rutter, Katon, Ciechanowski, 
Ludman et al., 2009; Pan, Lucas, Sun, van Damm, Franco, Willett et al., 2011; Young, von 
Korff, Heckbert, Ludman, Rutter, Lin et al., 2010; Winkley, Stahl, Chalder, Edmonds, & 
Ismail, 2007); b) absence of longitudinal data analysis on the relationship between depression 
and at least one diabetes complication (Boulanger, Zhao, Bao, & Russell, 2009; Bruce, Casey, 
Davis, Starkstein, Clarnette, Foster et al., 2006); c) no data on depression (Wexler, Grant, 
Wittenberg, Bosch, Cagliero, Delahanty et al., 2006); d) cross-sectional study design (Bhojani 
et al., 2008; Engum, Mykletun, Midthjell, Holen, & Dahl, 2005; Koroschetz, Rehm, Gockel, 
Brosz, Freynhagen, Tolle et al., 2011; Icks, Kruse, Dragano, Broecker-Preuss, Slominany, 
Mann et al., 2008); e) the relationship between depression and at least one diabetes 
complication was not examined (Whyte, Mulsant, Vanderbilt, Dodge, & Ganguli, 2004); f) 
diabetes complications were controlled for (Brown, Majumdar, Newman, & Johnson, 2006); 
and g) absence of discreet data on diabetes (Davis, Fujimoto, Juarez, Hodges, & Assam, 
2008). 
Ten articles fulfilled the inclusion criteria for the current systematic review. The selected 
characteristics of included studies are presented in Appendix 2. On closer examination, there 
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were six articles (three pairs of two articles) that were based on the same study populations. In 
the current review, they are presented as separate studies: 1)  Roy, Peng, & Roy, 2007 and 
Roy, Roy, & Affouf, 2007; 2) Lin, Rutter, Katon, Heckbert, Ciechanowski, Oliver et al., 2010 
and Sieu, Katon, Lin, Russo, Ludman, & Ciechanowski, 2011; and 3) Vileikyte, Peyrot, 
Gonzales, Rubin, Garrow, Stickings et al., 2009 and Gonzales, Vileikyte, Ulbrecht, Rubin, 
Garrow, Delgado et al., 2010. 
Sample sizes 
Studies’ sample sizes ranged from 333 to 4,623 participants. The ten studies provided a total 
of 20,469 participants.  
Setting 
Nine studies were conducted in the USA (Orchard, Olson, Erbey, Williams, Forrest, Kinder et 
al., 2003; Black, Markides, & Ray, 2003; Roy, Peng, & Roy, 2007; Roy, Roy & Affouf, 2007; 
Katon, Russo, Lin, Heckbert, Ciechanowski, Ludman et al., 2009; Vileikyte et al., 2009; 
Gonzales et al., 2010; Lin et al., 2010; Sieu et al., 2011), and one was conducted in Australia 
(Bruce et al., 2005).  
Participants 
Three studies included participants living with type 1 diabetes (Orchard et al., 2003; Roy, 
Peng, & Roy, 2007; Roy, Roy, & Affouf, 2007). Four studies included participants living with 
type 2 diabetes (Black, Markides, & Ray, 2003; Bruce et al., 2005; Lin et al., 2010; Sieu et 
al., 2011). Three studies recruited participants with either type 1 or type 2 diabetes (Katon et 
al., 2009; Gonzales et al., 2010; Vileikyte et al., 2009).  
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Quality of studies 
The results of the quality assessment of included studies are reported in Appendix 3. All ten 
studies used self-report measures to determine the presence of depressive symptoms, with one 
study using diagnostic criteria to measure lifetime depression (Black et al., 2003). One study 
used a subscale of a quality of life instrument (the General Health Status Questionnaire; 
Gudex & Kind, 1989) to determine depression status (Bruce et al., 2005). However, they 
validated the depression subscale on an independent sample of 51 people with type 2 diabetes. 
Diabetes status was self-reported in one study (Black et al., 2003), it was determined by using 
medical records in six studies (Orchard et al., 2003; Roy, Peng, & Roy, 2007; Roy, Roy, & 
Affouf, 2007; Katon et al., 2009; Lin et al., 2010; Sieu et al., 2011), and it was based on 
fasting blood glucose levels in one study (Bruce et al., 2005). The information was not 
provided in two studies (Vileikyte et al., 2009; Gonzales et al., 2010).  
Diabetes complications were assessed using self report in one study (Black et al., 2003), 
medical records in three studies (Katon et al., 2009; Lin et al., 2010; Sieu et al., 2011), a 
combination of medical records, self-report and screening tests in one study (Roy, Peng, & 
Roy, 2007), and screening instruments in five studies (Orchard et al,, 2003; Bruce et al,, 2005; 
Roy, Roy, & Affouf, 2007; Vileikyte et al., 2009; Gonzales et al., 2010).  
All studies gave an adequate description of the study population, including information such 
as age, gender, duration of diabetes, type of diabetes, education, and current diabetes 
complications. All studies but one (Roy, Peng, & Roy, 2007) controlled for confounding 
variables such as age, gender, education, socioeconomic status.   
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Blinding of baseline assessment for diagnosis of diabetes was not applicable for nine out of 
ten studies, as none of them had a group of participants without a diagnosis of diabetes. For 
one study (Black et al., 2003) blinding was not reported. 
Nine out of ten studies (except Gonzales et al., 2010) provided a description of follow-up 
numbers. Only six studies provided an adequate description of drop out rates (Roy, Peng, & 
Roy, 2007; Roy, Roy, & Affouf, 2007; Katon et al., 2009; Vileikyte et al., 2009; Lin et al., 
2010, Sieu et al., 2011) and only two studies conducted a comparison of drop-out rates 
between groups on key variables (Katon et al., 2009; Vileikyte et al., 2009). 
Follow-up period ranged between one and ten years. Follow-up period was considered 
sufficient if participants were followed up for 5 years and more (Stratton, Kohner, Aldington, 
Turner, & Holman, 2001). All but two studies had a sufficient follow-up period (Vileikyte et 
al., 2009; Gonzales et al., 2010). 
Key findings 
The key findings are summarised by direction of association between depression and diabetes 
complications and types of outcomes. 
1. Depression as a predictor of diabetes complications 
Eight studies investigated whether depression predicted the occurrence of diabetes 
complications.  
a) Depression and various microvascular and macrovascular diabetes complications  
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Two studies investigated the relationship between depression and diabetes complications, 
without presenting specific data for different types of advanced micro- or macrovascular 
complications.  
Black et al. (2003) examined the association between depression and incident diabetes micro- 
and macro-vascular complications in a 7-year longitudinal study involving Mexican 
Americans. Depression status was assessed using a self-report measure at baseline (Center for 
Epidemiologic Studies Depression Scale) and clinical diagnostic criteria (Composite 
International Diagnostic Interview Depression Module) at 2-year follow-up. Microvascular 
complications included nephropathy, neuropathy, retinopathy and amputations. 
Macrovascular complications included cardiovascular disease, stroke and kidney disease. The 
study results showed that both current depressive symptoms and lifetime depression predicted 
greater incidence of micro- and macrovascular complications. At the seven year follow-up, 
44% of participants with both current depressive symptoms and diabetes had developed 
macrovascular complications, compared with 30% who had neither condition. Forty-three 
percent of participants with both current depressive symptoms and diabetes had developed 
microvascular complications, compared with 36% with diabetes only, and 3% with neither 
condition. Similar results were found for lifetime depression. Sixty-four percent of 
participants with both diabetes and lifetime depression had macro-vascular complications at 
follow-up, compared with 38% with neither condition. Fifty-two percent of participants with 
both conditions developed microvascular complications, compared with 42% with diabetes 
only, and 7% with neither condition. The comorbidity of both diabetes and depression 
predicted not only increased risk of developing diabetes micro- and macro-vascular 
complications, but also earlier occurrence for microvascular complications. 
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Lin et al. (2010) prospectively examined the association between depression and risk of 
advanced micro- and macrovascular complications in people with type 2 diabetes. The study 
took place over a 5-year period. Depression status was assessed using the Patient Health 
Questionnaire (PHQ-9). Advanced microvascular complications included blindness, end-stage 
renal disease, amputations and renal failure deaths. Advanced macrovascular complications 
included myocardial infarction, stroke, cardiovascular procedures and deaths. The study 
findings showed that people who had major depression and diabetes at baseline, had a 36% 
higher risk of developing advanced microvascular complications and a 25% higher risk of 
developing advanced macrovascular complications five years later, than participants with 
diabetes and without depression.  
b) Depression and diabetic retinopathy  
Roy, Roy, & Affouf (2007) examined the longitudinal relationship between depressive 
symptoms, assessed using the Beck Depression Inventory (BDI, Beck, Ward, Mendelson, 
Mock, & Erbaugh, 1961) and diabetic retinopathy in African-Americans living with type 1 
diabetes. The results showed that being depressed at both baseline and 6 year follow-up was 
significantly associated with progression of diabetic retinopathy (OR=2.44, 95%CI: 1.01-5.88, 
p=0.049) and progression to proliferative diabetic retinopathy (OR=3.19, 95%CI: 1.30-7.87, 
p=0.01).  
Sieu et al. (2011) investigated whether depressive symptoms assessed using the Patient Health 
Questionnaire (PHQ-9, Spitzer, 1999) were associated with a higher incidence of diabetic 
retinopathy in people living with type 2 diabetes. Over a five-year follow-up period, baseline 
severity of depressive symptoms was associated with an increased risk of incident retinopathy 
(15% higher for each 5-point clinically significant increase in depression severity based on the 
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PHQ-9 total score), when controlling for socio-demographic characteristics (i.e. age, gender, 
ethnicity, education, and marital status), health risk behaviours (smoking, physical activity, 
BMI, HbA1c) and clinical characteristics (i.e. duration of diabetes, diabetes treatment, 
hypertension, diabetes complications).  
c) Depression and foot ulcers  
Gonzales et al. (2010) examined the association between depressive symptoms and the time-
to-onset of foot ulcers over an 18 months follow-up period. Participants had a diagnosis of 
type 1 or type 2 diabetes and moderate to severe diabetic peripheral neuropathy (DPN), but 
not peripheral vascular disease (PVD). Depressive symptoms were assessed using the 
Hospital Anxiety and Depression Scale (HADS, Zigmond & Snaith, 1983). Study results 
showed that depression is an independent predictor for the development of first foot ulcers. 
Each one standard deviation increase in HADS depression score was associated with a 48% 
higher risk of foot ulceration. There was no association between depression and an increased 
risk of developing subsequent foot ulcerations.  
d) Depression and incidence of coronary vascular disease (CVD)  
Orchard et al. (2003) examined independent risk factors for coronary artery disease (CAD) in 
people with type 1 diabetes. Depressive symptomatology was assessed using the Beck 
Depression Inventory and participants were followed-up over a ten-year period. Results 
showed that baseline depression scores were significantly associated with a 40% higher risk 
of incident angina (HR=1.40, 95%CI: 1.06-1.84, p=0.016) but not hard CAD events (i.e. 
myocardial infarction, catheter-proven stenoses, or CAD deaths) or total CAD events.  
Roy, Peng, & Roy (2007) examined the risk factors for CVD (either coronary artery disease 
(CAD) or stroke) in African-Americans with type 1 diabetes. Depressive status was assessed 
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using the Beck Depression Inventory and participants were followed-up over a 6 year period. 
Findings showed that baseline depression was an independent risk factor for incident CVD 
(OR=1.03, 95%CI: 1.001-1.06, p=0.04).  
e) Depression and cardiac mortality  
Bruce et al. (2005) investigated the impact of depression on all-cause and cardiac mortality in 
people living with type 2 diabetes. The study utilised a subscale of a quality of life instrument 
to establish depression status. However, the authors validated the subscale using an 
independent sample of people with type 2 diabetes. After adjustment for demographics, 
diabetes-related and cardiovascular risk factors, depression status was associated with a 
significant 56% increase in cardiac mortality (HR=1.56, 95%CI: 1.11-2.18, p=0.010). 
However, when baseline diabetes complications were added into the model, depression status 
was associated with a non-significant 15% increase in cardiac mortality (HR=1.15, 95%CI: 
0.80-1.68, p=0.45). Baseline micro- and macrovascular complications were a strong predictor 
of cardiac mortality. 
2. Diabetes complications as predictors of depression  
Two studies investigated whether diabetes complications predicted depression (Katon et al., 
2009; Vileikyte et al., 2009). 
i) Diabetic peripheral neuropathy and depression 
Vileikyte and colleagues (2009) examined the temporal relationships between diabetic 
neuropathy (DPN) severity measured by the neuropathy disability score (NDS) and the 
vibration perception threshold (VPT), DPN somatic experiences (symptoms and foot 
ulceration), DPN psychological consequences (restrictions in activities of daily living [ADL] 
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and social self-perception) and depressive symptoms measured by Hospital Anxiety and 
Depression Scale – depression items (HADS-D). They found that baseline NDS was 
significantly associated with increased depressive symptoms at 18 months follow-up (β=0.10, 
p=0.01). However, the association became non significant when baseline DPN symptoms 
were introduced in the model and baseline unsteadiness levels were significantly associated 
with increased depressive symptoms (β=0.16, p=0.001). In the final model, baseline 
unsteadiness (β=0.10, p<0.05), baseline ADL restrictions (β=0.18, p<0.01) and changes in 
social self-perception from 0 to 9 months (β=0.13, p<0.01) significantly predicted increased 
depressive symptoms. 
ii) Microvascular and macrovascular diabetes complications and depression 
Katon and colleagues (2009) examined the longitudinal relationship between microvascular 
and macrovascular events and procedures during follow-up and major depression at 5 year 
assessment. 
Microvascular events included retinopathy, and nephropathy. Macrovascular events included 
myocardial infarction, stroke, and peripheral vascular disease. Macrovascular procedures 
included coronary procedures (coronary artery bypass surgery, angioplasty, or stent 
replacement), cerebrovascular procedures (carotid endarterectomy) and peripheral vascular 
procedures (angioplasty or major vascular surgery of the aorta or peripheral vasculature).  
Results showed that coronary procedures during follow-up were significantly associated with 
92% higher risk of prevalent major depression at 5 year assessment (p<0.05). Microvascular 
or macrovascular events or other macrovascular procedures were not significantly associated 
with higher risk of major depression.  
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DISCUSSION 
Ten studies were included in the current systematic review, involving 20469 participants. 
Overall, the relationship between depression and diabetes complications appears to be 
bidirectional.  
Eight studies investigated the relationship between baseline depression status and the incident 
micro- and macrovascular diabetes complications at follow-up. Baseline depression status was 
significantly associated with an increased risk of developing micro- and macrovascular 
diabetes complications, particularly retinopathy, development of first foot ulcers, angina, and 
CVD.  
Two studies investigated the relationship between baseline diabetes complications and 
depression status at follow-up. Diabetic neuropathy symptoms and psychological 
consequences (but not severity of neuropathy) were significantly associated with increased 
depressive symptoms at follow-up. Coronary procedures (but not micro- or macrovascular 
events, cerebrovascular procedures or peripheral vascular procedures) were significantly 
associated with incident major depression at follow-up.  
Overall, the quality of the studies was adequate. Only one study (Katon et al., 2009) had good 
methodological quality (i.e. provided all the information set out in the Quality assessment 
section).  
Potential explanatory pathways 
a) Depression leading to incident diabetes complications 
 35 
A possible explanation relates to the physiological changes associated with depression. 
Depression has been linked to a dysregulation of the hypothalamic-pituitary-adrenal axis, 
activation of the sympathetic nervous system and an increase in pro-inflammatory factors 
(Katon, 2003; Musselman, 2003; Golden, 2007; Lustman, Penckofer, & Clouse, 2007). The 
resulting changes i.e. increase in circulating levels of cortisol, catecholamines, cytokines and 
platelet and endothelial cell adhesion factors (Katon, 2003; Miller, Stetler, Carney, Freedland, 
& Banks, 2002; Raison, Capuron, & Miller, 2006) may lead to increase insulin resistance and 
glycaemic fluctuation (Musselman, 2003). Retinal vessels are reported to be particularly 
sensitive to glycaemia variability (Nalysnyk, Hernandez-Medina, & Kirshnarajah, 2010; 
Weber & Schnell, 2009), resulting in microvascular lesions and neuroretinal damages leading 
to diabetic retinopathy (Cheung, Mitchell, & Wong, 2010).  
Another potential explanation relates to health behaviours. Makine, Karsidag, & Kadiougly 
(2009) found that depressed patients with diabetes tended to delay starting the insulin 
treatment, which in turn may contribute to a higher risk of developing diabetes complications. 
Also, people with diabetes who were depressed were less likely to engage in physical exercise 
(Bruce et al., 2005), less likely to adhere to diet programmes and to medication (Lin, Katon, 
& von Korff, 2004; Peyrot & Rubin, 1999).  
Self-efficacy may partially explain the relationship between depression and incident diabetes 
complications. Self-efficacy is a key concept in Bandura’s Social Cognitive Theory (Bandura, 
1997) and is defined as an individual’s belief in their own ability to perform a specific task 
(Krichbaum, Aarestad, & Buethe, 2003). Self-efficacy appears to mediate the relationship 
between depressive symptoms and glycaemic control (Cherrington, Wallston, & Rothman, 
2010). Low mood could lead to a poor sense of self-efficacy, which in turn leads to reduced 
adherence to self-care behaviours. Poor diabetes self-management leads to poor glycaemic 
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control, which in turn is known to increase the risk of developing diabetes complications. 
(Genuth, 1995; Klein, 1995; Lehto, Ronnemaa, Pyorala, & Laakso, 1996; Standl, 
Balletshofer, Dahl, Weichenbain, Stiegler, & Hormann, 1996; UKPDS Group, 1998). 
b) Diabetes complications leading to incident depression 
A possible explanation is that depression results from the psychological burden of living with 
diabetes and its related complications and disabilities (Campayo, Gomez-Biel, & Lobo, 2011; 
Pouwer et al., 2003; Renn, Feliciano, & Segal, 2011; Talbot & Nouwen, 2000).   
The diathesis-stress model of depression (Burke & Elliott, 1999) could be used as a 
framework to explain the link between diabetes complications and incident depression. The 
model emphasises interactions between social, cognitive, and biological vulnerability factors 
leading to an increase in one’s susceptibility to depression. Biological vulnerabilities may 
include a genetic predisposition to depression, temperament, and gender. Cognitive/affective 
vulnerabilities may include low self-esteem, a negative attribution style, external locus of 
control, and unsuccessful coping strategies. The social/behavioural component may include 
poor social relationships. In the diathesis-stress model for depression, particular features of 
diabetes as a chronic illness (such as illness severity represented by the presence of diabetes 
complications) could be viewed as stressors that interact with existing social, cognitive, and 
biological vulnerability factors to increase one’s vulnerability to other stressors and/or 
precipitate the onset of depression (Burke & Elliott, 1999).  
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Limitations of this systematic review 
The results of this study should be interpreted with caution, due to reasons outlined below.  
The current systematic review included only articles published in the English language, 
potentially missing relevant publications. The grey literature (unpublished papers, conference 
abstracts etc) was not scanned.   
Only one study used a comparable group of participants without diabetes complications 
(Black et al., 2003). Three studies used participants of a particular ethnicity (Black et al., 
2003; Roy, Roy, & Affouf, 2007; Roy, Peng, & Roy, 2007) limiting the generalisability of 
findings.  
The assessment of depression status varied greatly between studies and was based on self-
report questionnaires. Fisher, Skaff, & Mullan (2007) found that self-reported depressive 
symptoms in people living with diabetes tend to be suggestive of general emotion and 
diabetes-specific distress, rather than indicative of a depressive disorder. This might have 
resulted in an overestimation of clinically significant depression rates.  
Most studies did not differentiate between current depressive symptoms and history of 
depression. Katon, von Korff, & Lin (2004) found that 70% of participants with diabetes 
described their depressive symptoms as present for 2 years or more. Also, no data were 
collected regarding various depressive states over time, as depression can occur over a long 
period of time or it can manifest itself through repeated shorter episodes. Lustman et al. 
(1997) showed that 70% of participants with diabetes and major depression relapsed, with an 
average of four episodes over a 5-year interval. In addition, there are no data on depression 
medication and its impact.  
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For the purpose of this review, it was very difficult to ascertain what constitutes a sufficient 
follow-up period. However, most studies indicate that the condition develops very insidiously 
and that it takes at least a few years if not decades before diabetes complications can be 
diagnosed. 
A meta-analysis was not conducted, as it was deemed to be beyond the purpose of the current 
project.  
Further research and clinical implications 
Longitudinal studies provide evidence of a temporal association between depression and 
diabetes complications, but no clear causation. The associations between depression and 
diabetes complications observed in this systematic review warrant further investigation, in 
order to identify potential causal pathways.  
Due to the negative consequences of depression in people with diabetes, such as an increased 
risk of developing complications, early detection and treatment for depression is important. 
Further research is needed in order to investigate whether interventions for depression in 
people with diabetes result in a delay in the occurrence of diabetes complications. At the same 
time, further intervention studies are needed to explore whether appropriate management and 
support with diabetes complications may avert the occurrence of incident depression. 
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ABSTRACT 
Aims Postnatal depression is a common affective disorder following childbirth, affecting 
around 13% of women. Posnatal depression has been shown to affect both the mother and her 
baby, leading to mother-infant relationship difficulties and long-term child behavioural and 
cognitive problems, particularly for boys from disadvantaged backgrounds. Previous 
research showed that women with diabetes (pre-gestational or gestational diabetes) were 
almost twice as likely to experience depression in the perinatal period than women without 
diabetes. The current study aims to: i) establish the incidence and prevalence of postnatal 
depression in women with gestational diabetes in a general hospital UK population; ii) to 
investigate whether known risk factors of postnatal depression predict depression in women 
with gestational diabetes; iii) to investigate whether diabetes specific risk factors (e.g. 
problems with diabetes control, management, etc.) predict depression in women with 
gestational diabetes over and above general risk factors. Methods: Prospective longitudinal 
study. Results The incidence of postnatal depression in the current study was 11.5%. The 
prevalence of postnatal depression in the current study was 15.8%, indicating that the 
majority of women who are depressed postnatally are also depressed antenatally. Antenatal 
depression was a significant predictor of postnatal depression in women with gestational 
diabetes. Diabetes-specific factors were not significant predictors of postnatal depression, 
over and above known risk factors. However, the study had a small sample size. Conclusions 
Further research is needed to examine the role of diabetes-specific factors in predicting 
postnatal depression.  
 
Keywords: gestational diabetes, risk factors, postnatal depression 
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INTRODUCTION 
 
1.1. Postnatal depression 
Perinatal mental health problems following childbirth include a wide range such as ‘baby 
blues’, postnatal depression, anxiety, and puerperal psychosis, a serious condition requiring 
hospitalisation (Evins & Theofrastous, 1997). Postnatal depression is classified in DSM-IV as 
‘a depressive condition that often exhibits the disabling symptoms of dysphoria, emotional 
lability, insomnia, confusion, anxiety, guilt and suicidal ideation’ (APA, 1994).  A meta-
analysis of 59 longitudinal and epidemiologic studies provided estimates of the prevalence of 
PND in the region of 13%, ranging from 3 to 25% of women in the year following childbirth 
(O’Hara & Swain, 1996). A more recent systematic review of 28 cross-sectional, cohort and 
case-control studies estimated the incidence rates for postnatal depression between 7.8% and 
14.5%, and point prevalence rates for postnatal depression between 9.6% and 29.1% in the 
first six months following childbirth (Gavin, Bradley, Gaynes, Lohr, Meltzer-Brody, 
Gartlehner et al., 2005). 
Risk factors for postnatal depression include antenatal depression, antenatal anxiety, life 
stress, low levels of social support, previous history of depression, socioeconomic status, 
marital statisfaction, childcare stress, and infant temperament (Beck, 2001; Robertson, Grace, 
Wallington, & Stewart, 2004). 
Postnatal depression has been shown to affect both the mother and her baby, leading to 
mother-infant relationship difficulties (Loh & Vostanis, 2004) and long-term child 
behavioural (Alpern & Lyons-Ruth, 1993; Beck, 1999; Murray, Sinclair, Cooper, Ducournau, 
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& Turner, 1999; Sinclair and Murray, 1998) and cognitive problems (Kurtjens & Wolke, 
2001), particularly for boys from disadvantaged backgrounds (Sinclair & Murray, 1998). 
Treatment of postnatal depression leads to improved functioning of the mother, which in turn 
has a positive effect on the baby and the family as a whole (Wickberg & Hwang, 1996). 
The treatment of postnatal depression is as such a public health priority, and recent NICE 
guidance recommended that all women be screened for postnatal depression (usually at 6-8 
weeks and again at 3-4 months postnatally) using two questions to identify women 
experiencing difficulties (NICE, 2007). The questions (known at the Whooley questions) ask 
the following: ‘During the past month, have you often been bothered by feeling down, 
depressed, or hopeless?’ and ‘During the past month, have you often been bothered by little 
interest or pleasure in doing things?’. A third question is asked if the woman answers ‘yes’ to 
either of the initial questions: ‘Is this something you feel you need or want help with?’. 
Women experiencing such problems should be offered support from professionals, and 
voluntary organisations.  
1.2. Diabetes in pregnancy 
One-point-eight percent of all pregnancies are affected by pre-existing diabetes, while 
between 2 and 9% of all pregnancies are affected by gestational diabetes mellitus (Lawrence, 
Contreras, Wansu, & Sacks, 2008). Diabetes in pregnancy is associated with maternal and 
infant risks and complications (Evers, de Valk, & Visser, 2004; Feig & Palda, 2002). Women 
with gestational diabetes are at increased risk of developing type 2 diabetes (Bellamy, Casas, 
Hingorani, & Williams, 2009); their offspring are at increased risk of developing diabetes and 
cardiovascular diseases, as well as obesity later in life (Lindsay, 2000). Infants are more likely 
to be born prematurely and to suffer from congenital malformations (McIntyre, Thomae, 
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Wang, Idris, & Callaway, 2009). Women with gestational diabetes have similar rates of 
stillbirth as in the general population. However, women diagnosed with ‘gestational’ diabetes 
who have  unrecognised type 2 diabetes have a 2.5 fold higher risk of stillbirth than non-
diabetic pregnant women (Cundy, Gamble, Townend, Henley, MacPherson, & Roberts, 2000;  
Lapolla, Dalfra, Bonomo, Parretti, Mannino, Mello, et.al., 2009; Silver, Varner, Reddy, 
Goldenberg, Pinar, Conway, et.al., 2007). 
Hjelm et al. (Hjelm, Bard, Nyberg, & Apelqvist, 2005) interviewed women diagnosed with 
gestational diabetes in order to explore their beliefs about their condition. Participants 
expressed worries about the baby’s health, as well as fear about the future development of 
type 2 diabetes. Midwives providing care to pregnant women with gestational diabetes 
described their illness as a ‘snake in paradise’ (Persson, Hornsten, Winkvist, & Mogren, 
2011:80).  
1.3. Diabetes in pregnancy and mood states 
There is an emerging interest in the link between diabetes during pregnancy and perinatal 
mental health (Metzger, Buchanan, & Coustan, 2007). Previous literature has established a 
link between diabetes and depression in the general adult population (Anderson, Freedland, 
Clouse, & Lustman, 2001). While the relationship between diabetes and depression is 
reciprocal with depression leading to increased incidence of (type 2) diabetes (Mezuk, Eaton, 
Albrecht, & Golden, 2008) and diabetes increasing the risk of depression (Nouwen, Nefs, 
Caramlau, Connock, Winkley, Lloyd et al., 2011), several factors such as diabetes distress, 
glycaemic control, and diabetes complications were identified as mediators between 
depression and diabetes (Bailey, 1996). Moreover, behavioural factors such as reduced 
physical activity (Koopman, Pouwer, de Bie, van Rooji, Leusink, & Pop, 2009) and increased 
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food intake may also play a role (Sacco, Wells, Friedman, Matthew, Perez, & Vaughan, 
2007). 
Several studies looked at the relationship between diabetes in pregnancy and mood states. 
They reported inconsistent findings with regard to the association between depression, 
anxiety, and diabetes in the perinatal period. In some studies, high levels of anxiety and 
depression were associated with a diagnosis of gestational diabetes (Danniels, Grenyer, Davis, 
Coleman, Burgess, & Moses, 2003; York, Brown, Armstrong, & Jacobsen, 1996). Other 
studies reported that the mood profile did not differ significantly between women with 
gestational diabetes and women without diabetes in pregnancy (Kim, Brawarsky, Jackson, 
Fuentes-Afflick, & Hass, 2005; Mautner, Greimer, Trutnovsky, Daghofer, Egger, & Lang, 
2009). Insulin therapy did not account for higher scores of depression or anxiety (Langer & 
Langer, 1994; Danniels et al., 2003). Women with pre-gestational diabetes experienced higher 
levels of depression than women with gestational diabetes (Langer & Langer, 2000). 
Glycaemic control affected emotional states for women with gestational diabetes (but not for 
women with pre-gestational diabetes), with poor glycaemic control accounting for more 
emotional distress (Langer & Langer, 1998; 2000).  
However, most studies did not use outcome measures specific to postnatal depression such as 
the Edinburgh Postnatal Depression Scale (Cox, Holder, & Sagovsky, 1987). They had either 
short or no postnatal follow up. In addition, the majority of studies were inadequately 
powered and did not account for known postnatal depression risk factors such as previous 
history of depression and anxiety, marital status, social support, self esteem, and infant 
temperament. Few studies presented information on whether participants in the control group 
were screened for diabetes. No studies were conducted in the UK.   
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In contrast, a large retrospective cohort study (N=11024 participants) conducted by Backes 
Kozhimanhil and colleagues (Backes Kozhimanhil, Pereira, & Harlow, 2009) was adequately 
powered and showed that women with diabetes (pre-gestational or gestational diabetes) were 
almost twice as likely to experience depression in the perinatal period (defined as depression 
in the six months prior to delivery and twelve months postpartum) than women without 
diabetes (OR = 1.85; 95% CI= 1.45-2.36).  However, this study was conducted in the US with 
a low income population. Coming from a disadvantaged socio-economic background may 
have a bigger impact in people with diabetes because of the cost of medication, dietary habits, 
etc., which may increase stress levels, thus contributing to the higher levels of depression. The 
prevalence data in this study is consistent with systematic reviews and meta-analyses 
examining the prevalence of depression in people with diabetes in the general population 
(Anderson et al., 2001; Ali, Stone, Peters, Davies, & Khunti, 2006).  
Understanding whether gestational diabetes is associated with postnatal depression is 
important. The current study aims to add to the existing literature by examining further the 
incidence and prevalence of postnatal depression in women with gestational diabetes in a 
general hospital UK population. It also aims to explore known and diabetes-specific risk 
factors for postnatal depression in this particular group, namely women with gestational 
diabetes.  
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1.4. Study aims♣ 
The study aims to: i) establish the incidence and prevalence of postnatal depression in women 
with gestational diabetes in a general hospital UK population; ii) investigate whether known 
risk factors of postnatal depression predict depression in women with gestational diabetes; iii) 
investigate whether diabetes specific risk factors (e.g. diabetes distress, diabetes-specific 
social support) predict depression in women with gestational diabetes over and above general 
risk factors. 
                                                          
♣ The current study is part of a larger study also investigating the link between perinatal anxiety and gestational 
diabetes. 
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METHODS 
2.1. Study design 
The current project is a prospective longitudinal study, involving women with a diagnosis of 
gestational diabetes (GDM). Participants were recruited from two hospitals in the West 
Midlands. One hospital’s catchment’s area included mainly a British White middle-class 
population, with pockets of socially deprived areas. The other hospital’s catchment’s area 
included a more diverse, mainly socially disadvantaged population, with pockets of wealth. 
The study received ethical approval from the West Midlands Research Ethics Committee, 
reference number 10/H1208/61 (Appendix 1).  
2.2. Recruitment procedure 
Women at high risk of developing diabetes during pregnancy were referred to the hospital by 
the community midwife and invited to undergo an OGTT test (oral glucose tolerance test). If 
the OGTT test was positive, the diabetes specialist nurse/midwife invited them to attend a 
joint diabetes/obstetrics clinic at 30/31 weeks gestation. When attending the clinic, women 
were approached and invited to participate in the current study (Appendices 2-4). Participants 
were followed-up at six weeks postnatal using postal questionnaires. Telephone reminders 
were used two weeks after the postal questionnaires were sent out. 
Participants’ inclusion criteria: all pregnant women identified at risk of developing gestational 
diabetes. Known risk factors for gestational diabetes include: previous diagnosis of 
gestational diabetes, first degree relative with type 2 diabetes, increasing age, ethnicity (i.e. 
South-Asian), pre-pregnancy obesity, and previous pregnancy which resulted in a child with 
 61 
high birth weight (>90th centile, or >4,000g), (Di Cianni, Volpe, Lencioni, Miccoli, Cuccuru, 
Ghio et al., 2003). 
Participants’ exclusion criteria: living with pre-existing diabetes, < 18 years old, unable to 
communicate in English, receiving specialist psychiatric care or suffering from any mental 
illnesses (other than PND) or learning difficulties.  
2.3. Outcome measures 
Postnatal depression: The outcome of interest was depressive symptoms at six weeks 
postnatal, as measured by the Edinburgh Postnatal Depression Scale (EPDS; Cox et al. 
(1987). The EPDS was validated on a sample of new mothers and consists of ten items using 
a 4-point Likert scale ranging from 0 (yes, most of the time) to 3 (no, not at all). Examples of 
scale items include ‘I have looked forward with enjoyment to things’ and ‘I have blamed 
myself unnecessarily when things went wrong’. The scale has been used extensively in 
perinatal research, as well as in clinical practice as a screening instrument for women with 
postnatal depressive symptoms. The sensitivity of the EPDS is 86%, and specificity is 78% 
(Cox et al, 1987). Cronbach’s alpha in the current study was .89. 
Antenatal depression: antenatal depressive symptoms were measured using the depression 
subscale of the Hospital Anxiety and Depression Scale (HADS-D; Zigmond & Snaith, 1983). 
The scale measures the absence of positive affect and pleasure of every day tasks; it was 
designed to discriminate between somatic symptoms of physical illnesses and the assessment 
of anxious and depressive symptoms in medically ill people (Zigmond & Snaith, 1983). The 
subscale comprises 7 items using a 4-point Likert scale ranging from 3 (yes, definitely) to 0 
(no, not at all). Examples of scale items include ‘I still enjoy the things I used to enjoy’ and ‘I 
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feel miserable and sad’. The HADS was administered at two points in time, i.e. 2nd/3rd 
trimester, and six weeks postnatal. Cronbach’s alpha for the current sample was .80. 
Antenatal anxiety: antenatal anxiety symptoms were measured using the anxiety subscale of 
the HADS (HADS-A, Zigmond & Snaith, 1983). The subscale comprises 7 items using a 4-
point Likert scale ranging from 3 (yes, definitely) to 0 (no, not at all). Examples of scale items 
include ‘I feel anxious when I go out of the house on my own’ and ‘I am restless and can’t 
keep still’. 
Social support: the social support subscale of the Postpartum Depression Predictors Inventory 
(PPDI-R; Beck, 2002) was used to assess practical and emotional support. The social support 
subscale consists of 12 items using ‘yes’ or ‘no’ answers. Examples of scale items include 
‘Do you feel you receive adequate practical support from your partner?’ and ‘Do you feel you 
can confide in your partner?’. The PPDI-R was designed based on the results of a meta-
analysis on risk factors for postnatal depression (Beck, 2001). The PPDI-R has concurrent 
validity and internal consistency (Cronbach’s ά=0.83), (Records, Rice, & Beck, 2007). 
Diabetes-related emotional distress: Problem Areas in Diabetes survey (PAID; Polonsky, 
Anderson, Lohrer, Welch, Jacobson, & Schwartz, 1995) was used to measure diabetes-related 
emotional distress. The scale comprises 20 items using a 5-point Likert scale ranging from 0 
(not a problem) to 4 (serious problem). Examples of scale items include ‘Feelings constantly 
concerned about food and eating’ and ‘Worrying about low blood sugar reactions’. The scale 
has been used extensively in diabetes research and has high internal reliability (Cronbach’s 
ά=0.95) and concurrent validity.  
Perceived diabetes interference, severity and diabetes-specific social support: the 
Multidimensional Diabetes Questionnaire (MDQ, Talbot, Nouwen, Gingras, Gosselin, & 
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Audet, 1997) is a 16-item scale using a 7-point Likert scale ranging from 0 (not at all) to 6 
(extremely). The scale includes measures of perceived interference, severity, and diabetes-
specific social support (mediating link stress to depression, Talbot, Nouwen, Gingras, 
Belanger, & Audet, 1999). The Cronbach’s alpha for the current sample was .86. 
We also collected data on demographic characteristics (age, education, socioeconomic status, 
marital status, number of children), history of depression, and obstetric outcome (mode of 
delivery, outcome of delivery, preterm/term delivery). (Appendices 6&7) 
2.4. Sample size 
Sample size was determined using a ‘rule of thumb’ suggested by Tabachnich and Fiddell 
(2007), which states that the number of participants required when using a multiple regression 
analysis is at least 50 + 8 X the number of predictor variables being entered into the 
regression. In the current study, the number of predictor variables was 13, and therefore the 
sample size requirement was 154 participants (50 + 8 X 13 = 154). 
2.5. Statistical methods 
Descriptive methods were used to describe participant’s characteristics. Independent samples 
t-tests, Mann-Whitney U tests (where there were violations to the assumption of a normal 
distribution), and chi-square analyses were used to compare between participants who were 
followed up at six weeks postnatal with the ones who dropped out of the study. Hierarchical 
multiple regression was used to examine the relationship between potential risk factors and 
postnatal depression. 
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RESULTS 
 
137 women (based on availability) were invited to participate in the study. 11 did not meet the 
eligibility criteria (i.e. non-English speakers).12 declined to participate. 114 consented to 
participate and 77 returned baseline questionnaires. 38 (49.4%) participants returned the six 
week follow-up questionnaires and 39 (50.6%) were lost to follow-up (see Figure 1 below).  
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Figure 1. Study sample recruitment 
 
The baseline sociodemographic and clinical characteristics of participants who completed the 
baseline questionnaire (N=77) are presented in the table 1 below. 
 
Assessed for eligibility 
(based on availability): 
N=137 
Invited to participate 
N=126 
Excluded: 11  
(non-English speakers) 
Declined participation: 
12 
Consented into the study 
N=114 
Questionnaires not 
returned: 
37 
Baseline data: 
N=77 
Lost to follow-up 
39 (50.6%) 
6 weeks follow-up: 
N=38 (49.4%) 
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Table 1. Baseline demographic and clinical characteristics for all participants 
Characteristics  Total sample (N=77) 
Age   
Range  22-42 
Mean (SD) 32.3 (4.8) 
Marital status N (%)  
Single/separated/divorced/widowed  4 (5.2%) 
Married/cohabiting  73 (94.8%) 
Number of children (range) 0-4 
Ethnicity N (%)  
White British 45 (58.4%) 
White other 7 (9.1%) 
British Asian 16 (20.8%) 
British Black African 1 (1.3%) 
Other 5 (6.5%) 
SES (deprivation scores)a   
Range  2.2- 71.6 
Mean (SD) 20.4 (16.5) 
Education – 1st degree and above N (%) 41 (53.2%) 
Pregnancy planned N (%)  
Yes 54 (70.1%) 
No 23 (29.9%) 
Pregnancy wanted N (%)  
Yes 77 (100%) 
History of depression N (%)  
Yes  25 (32.5%) 
No  52 (67.5%) 
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Characteristics  Total sample (N=77) 
Antenatal depression (HADS-D) N (%)  
Yes 6 (7.8%) 
No 69 (89.6%) 
Antenatal anxiety (HADS-A) N (%)  
Yes 6 (7.8%) 
No 70 (9.1) 
aDeprivation scores were computed using the National Statistics Postcode Directory (available 
at www.census.ac.uk)  
Out of the 77 women who completed the baseline questionnaires, 38 women (49.4%) 
completed the six weeks follow-up questionnaires. Table 2 describes the comparisons 
between participants who were followed-up with the ones who were lost to follow-up on 
sociodemographic and clinical characteristics.  
Table 2. Comparison between participants who returned the six weeks questionnaires and the 
ones who were lost at follow-up 
Characteristics  
Follow-up 
N=38 
Drop-out 
N=39     
p values 
Age     
Range  22-42 23-42  
Mean (SD) 32.3 (4.7) 32.4 (4.9) ns 
Marital status N (%)    
Single/separated/divorced/widowed  2 (5.3%) 2 (5.1%)  
Married/cohabiting  36 (94.7%) 37 (94.9%) ns 
Number of children (range) 0-4 0-4 ns 
Ethnicity N (%)    
White British 25 (65.8%) 20 (51.3%)  
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Characteristics  
Follow-up 
N=38 
Drop-out 
N=39     
p values 
White other 4 (10.5%) 3 (7.7%)  
British Asian 6 (15.8%) 10 (25.6%)  
British Black African 1 (2.6%) -  
Other 1 (2.6%) 4 (10.3%) ns 
SES (deprivation scores)     
Range  2.6-71.6 2.2-63.6  
Median 17.51 16.05 ns 
Education –1st degree and above N (%) 24 (63.2%) 17 (43.6%) ns 
Pregnancy planned N (%)    
Yes 28 (73.7%) 26 (66.7%)  
No 10 (26.3%) 13 (33.3%) ns 
Pregnancy wanted N (%)    
Yes 38 (100%) 39 (100%) N/A 
History of depression N (%)    
Yes  9 (23.7%) 16 (41.1%)  
No  29 (76.3%) 23 (58.9%) ns 
Antenatal depression (HADS-D) N (%)    
Yes 2 (5.3%) 4 (10.3%)  
No 35 (92.1%) 34 (87.2%) ns 
Antenatal anxiety (HADS-A) N (%)    
Yes 1 (2.6%) 5 (12.8%)  
No 36 (94.7%) 34 (87.2%) ns 
Delivery outcome N (%)    
Live baby  32 (84.2%) 27 (69.2%)  
Special care 3 (7.9%) 2 (5.1%)  
Transferred out 1 (2.6%) - ns 
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Characteristics  
Follow-up 
N=38 
Drop-out 
N=39     
p values 
Mode of delivery N (%)    
Normal vaginal delivery 12 (31.6%) 16 (41.1%)  
Instrumental delivery 6 (15.8%) 1 (2.6%)  
Elective caesarean 8 (21.1%) 7 (17.9%)  
Caesarean section in labour 10 (26.3%) 5 (12.8%) ns 
Preterm N (%) 2 (5.3%) 2 (5.1%) ns 
ns=not significant; N/A=not applicable 
There were no significant differences on demographic characteristics, obstetric outcomes, 
history of depression, antenatal depression, or antenatal anxiety between the women who 
returned the six week follow-up questionnaires and the ones who were lost at follow-up.  
Incidence and prevalence of postnatal depression 
Incidence rates refer to the number of new cases of depression, measured at six weeks 
postnatal. Prevalence rates refer to the total number of women with depression at six weeks 
postnatal (i.e. it includes women with antenatal depression). The incidence and prevalence of 
postnatal depression was assessed using the EPDS (EPDS score > 9) at six weeks postnatal. 
The incidence of postnatal depression in the current study was 11.5%. The prevalence of 
postnatal depression in the current study was 15.8%. 
Risk factors for postnatal depression in women with gestational diabetes 
Variables of interest were first examined for normality. The Kolmogorov-Smirnov test of 
normality indicated that antenatal anxiety, antenatal depression, diabetes distress and diabetes 
severity were normally distributed (p>0.05, Appendix 1). The remaining variables (child care 
stress, infant temperament, life stress, social support, marital satisfaction, deprivation scores, 
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diabetes social support, and diabetes interference) were not normally distributed (p<0.05, 
Appendix 8). Independent samples t-tests, Mann-Whitney U tests (where there were 
violations to the assumption of a normal distribution), and chi square tests (with Yates 
Continuity Correction) were used in order to compare women with postnatal depressive 
symptoms at six weeks postnatal (EPDS>9) with women without postnatal depressive 
symptoms (EPDS≤ 9) on various known risk factors for postnatal depression (Beck, 2001; 
Roberston et al., 2004). The results are presented in Table 3 below. 
Table 3. Comparisons between depressed and non-depressed women  
Variables No postnatal 
depression 
Postnatal 
depression 
t, z or χ2  
Antenatal anxiety (HADS-A)  
Mean (SD) 
4.45(3.19) 8.67(2.07) -3.09** 
Antenatal depression (HADS-D) 
Mean (SD) 
4.58(2.85) 7.67(2.94) -2.42* 
Child care stress (PPDI-R) 0.00 1.50 -1.93* 
Infant temperament (PPDI-R) 0.00 0.50 -1.07 
Life stress (PPDI-R) 0.00 1.00 -2.90** 
Social support (PPDI-R) 0.00 2.00 -1.93* 
Marital satisfaction (PPDI-R) 0.00 0.00 -0.62 
Deprivation scores 17.8 17.14 -0.02 
Diabetes distress (PAID) M(SD) 21.99(17.66) 36.04(16.29) -1.74 
Diabetes social support (MDQ) 4.88 3.00 2.15* 
Diabetes severity (MDQ) M(SD) 2.54(1.36) 3.61(1.51) -1.81 
Diabetes interference (MDQ) 0.83 2.33 -1.95* 
History of depression   N (%) 7(21.9) 2(33.3) 0.01 
Data are median scores unless otherwise indicated; *p<0.05; **p<0.01 
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Antenatal anxiety, antenatal depression, social support, life stress, child care stress, diabetes 
social support, and diabetes interference significantly differed between women with and 
without postnatal depression symptoms at six weeks postnatal.  
A correlation matrix containing all antenatal variables is presented in Table 4 below.  
Table 4. Correlation matrix between study variables 
Variables Antenatal 
depression 
Antenatal 
anxiety 
Social 
support 
Life 
stress 
Diabetes 
social 
support 
Diabetes 
interference 
Antenatal 
depression 
1.00 0.57*** 0.20 0.15 -0.22* 0.50*** 
Antenatal 
anxiety 
0.57*** 1.00 0.19 0.19 -0.29* 0.42*** 
Social support 0.20 0.19 1.00 0.36*** -0.20 0.15 
Life stress 0.15 0.19 0.36*** 1.00 -0.15 0.17 
Diabetes 
social support 
-0.22* -0.29* -0.20 -0.15 1.00 -0.34** 
Diabetes 
interference 
0.50** 0.42*** 0.15 0.17 -0.34** 1.00 
All data represent Spearman’s rho correlation coefficient; *p<0.05; **p<0.01, ***p<0.001 
Variables that were not normally distributed (social support, life stress, child care stress, 
diabetes social support, and diabetes interference) were transformed in order to achieve 
normal distribution before entering them in a hierarchical multiple regression. Different types 
of transformations were performed, as recommended by Tabachnick & Fidell (2007); social 
support, life stress and child care stress did not improve, and were therefore entered in the 
regression in their original format (Tabachnick & Fidell 2007); for diabetes social support a 
‘reflect and square root’ transformation was used [new variable=SQRT(K-old variable), 
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K=largest possible value +1], while diabetes interference was transformed using a ‘square 
root’ transformation [new variable=SQRT(old variable)], (Tabachnick & Fidell 2007). 
All variables were entered in a hierarchical multiple regression in order to assess whether 
diabetes-specific factors (diabetes social support, diabetes interference) were able to predict 
depressive symptoms, after controlling for known postnatal depression risk-factors (antenatal 
anxiety, antenatal depression, social support, life stress, child care stress). (Appendix 9) 
Data was checked for collinearity. Tolerance values were greater than 0.1 and VIF values 
were less than 10. The data was also checked for outliers, inspecting the Mahalanobis 
distances; the critical value was 15.14, which was less than 24.32 (the maximum critical value 
for seven independent variables, Tabachnick & Fidell, 2007).  
Antenatal depression, antenatal anxiety, social support, and life stress were entered at Step 1 
(model 1), explaining 41% of the variance in postnatal depressive symptoms. Antenatal 
anxiety was a significant predictor for postnatal depression. After entry of child care stress at 
Step 2 (model 2), the total variance explained by the model as a whole was 48%, 
F(5,15)=2.79, p<0.05. Child care stress explained an additional 7% of the variance in 
depressive symptoms, R square change=0.07, F change (1.15)=1.99, p=0.18. In model 2, 
antenatal anxiety was a significant predictor for postnatal depression. However, the R square 
change was not significant, meaning that the additional variable (child care stress) did not add 
a significant amount of variance to the first model. 
Diabetes distress and diabetes-specific social support were entered at Step 3 (model 3). The 
total variance explained by the model was 59%, F (7,13)=2.77, p<0.05. The two variables 
explained an additional 11% of the variance in depressive symptoms, R square change=0.11, 
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F change (2, 13)=1.89, p=0.19. Adding diabetes social support and diabetes interference to 
the model did not lead to a better prediction model (R square change not significant). 
Table 5. Predictors of postnatal depressive symptoms in women with gestational diabetes 
Model Predictors β F R2 R2 change F change 
1 Antenatal 
depression 
0.04 2.82* 0.41 0.41 2.8 
Antenatal anxiety 0.52* 
Social support 0.13 
Life stress 0.14 
2 Antenatal 
depression 
-0.004 2.79* 0.48 0.07 1.98 
Antenatal anxiety 0.50* 
Social support 0.09 
Life stress 0.09 
Child care stress 0.28 
3 Antenatal 
depression 
-0.08 2.77* 0.59 0.11 1.88 
Antenatal anxiety 0.43 
Social support 0.01 
Life stress 0.12 
Child care stress 0.33 
Diabetes social 
support 
-0.20 
Diabetes 
interference 
0.22 
*p<0.05 
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Discussion 
4.1. Summary of findings 
The first aim of the current study was to investigate the incidence and prevalence of postnatal 
depression in women with gestational diabetes in a general hospital UK population. The 
incidence was 11.5%. The prevalence of postnatal depression was 15.8%. The incidence rate 
of postnatal depression in this study was lower than the prevalence rate, indicating that the 
majority of women depressed postnatally were also depressed antenatally. The incidence rate 
in this study was slightly higher than the one found by the Backes Kozhimanhil study (Backes 
Kozhimanhil, Pereira, & Harlow, 2009), which reported a 9.6% incidence of depression 
amongst women with diabetes during pregnancy. The prevalence rate in this study (15.8%) is 
higher than the prevalence rate of the Backes Kozhimanhil study (Backes Kozhimanhil 
Pereira, & Harlow, 2009); they reported a 13.4% prevalence of postnatal depression amongst 
women with diabetes (pre-gestational or gestational diabetes). The difference in findings 
could be attributed to several factors. First, the Backes Kozhimanhil study was conducted in 
the US, while the current study was conducted in the UK. Second, in more recent years, 
postnatal depression has had some media popularity with a variety of well known celebrities 
admitting to have suffered from it, perhaps leading to an increased awareness of the illness, 
which in turn facilitates help-seeking behaviour (Highet, Gemmill & Milgrom, 2011; Sword, 
Busser, Ganann, McMillan & Swinton, 2008). 
The second aim of the current study was to investigate whether known risk factors for 
postnatal depression in the general population predict postnatal depression in women with 
gestational diabetes. Current study findings showed that antenatal anxiety was the only factor 
that significantly contributed to the prediction of postnatal depression in women with 
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gestational diabetes. The model also included antenatal depression, social support, and life 
stress, and explained 41% of the variance in depressive symptoms. The findings are consistent 
with the results of a meta-analysis conducted by Beck (2001), showing a moderate effect of 
antenatal anxiety in the prediction of postnatal depression in the general population (effect 
size r=0.45). The findings are also consistent with a systematic review conducted by 
Robertson and colleagues, which showed that anxiety during pregnancy was a predictor for 
postnatal depression (Robertson et al., 2004). Coelho and colleagues explored in greater detail 
the relationship between various forms of anxiety (generalized anxiety disorder, social 
phobia) and postnatal depression, and found that a diagnosis of antenatal generalized anxiety 
disorder independently predicted depression after delivery (Coelho, Murray, Royal-Lawson & 
Cooper, 2011).  Further research is needed to investigate whether reducing the level of 
anxiety during pregnancy would lead to a reduction in postnatal depression.  
It is surprising that antenatal depression was not a significant predictor for postnatal 
depression, considering that most women who were depressed antenatally continued to be 
depressed postnatally (see incident and prevalence rates above). This could be attributed to 
the small sample size relative to the number of variables entered in the regression, and to the 
high level of inter-correlation between antenatal anxiety and antenatal depression 
(Spearman’s rho=0.57, p<0.001). 
When child care stress was added to the model (model 2), the model explained 48% of the 
variance, but model change was not significant. Child care stress was not found to be a 
significant predictor of postnatal depression. Antenatal anxiety continued to be a significant 
predictor of postnatal depression. The findings are not consistent with the results of a meta-
analysis conducted by Beck (2001), which showed a moderate effect of child care stress in the 
prediction of postnatal depression in the general population (effect size r=0.46). At the same 
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time, in contrast with the findings of the Beck (2001) meta-analysis, the findings of the 
current study showed that antenatal depression, social support, and life stress were not 
significant predictors of postnatal depression. This could be attributed to the small sample size 
relative to the number of variables entered in the regression, and to the high level of inter-
correlation between these variables. Also, antenatal social support, life stress and child care 
stress were measured using a subscale of the PPDI-R. The subscale uses only ‘yes’ or ‘no’ 
answers, leading to a limited range of scores. 
The third aim of the study was to investigate whether diabetes-specific risk factors predict 
depression in women with gestational diabetes, over and above general risk factors. Diabetes-
specific social support during pregnancy and diabetes interference were not significant 
predictors of postnatal depression, when controlling for known risk factors. In the third 
regression model, the two variables explained an additional 11% of the variance, bringing the 
total variance explained by the model to 59% (but no significant difference in variance 
between model 2 and model 3). Antenatal anxiety was no longer a significant predictor of 
postnatal depression. This is perhaps an indication that the effect of antenatal anxiety on 
postnatal depression is moderated by diabetes social support and diabetes interference.  
Two dominant models were proposed to explain the process through which social support has 
an effect on physical and psychological well-being: the direct or main-effect model and the 
buffering model. The direct effect model suggests that social support is beneficial all the time, 
irrespective whether the person is under stress (i.e. there is a direct, linear relationship 
between social support and well-being). The buffering model posits that support is related to 
well-being when the person is under stress; social support ‘buffers’ oneself from the 
pathogenic influence of stressful events (Cohen & Wills, 1985). The wider literature suggests 
that there is evidence supporting both models (Taylor, 2011). The results of the current study 
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(i.e. the effect of antenatal anxiety on postnatal depression is potentially mediated by diabetes 
social support – see previous paragraph) would support the latter model, i.e. that diabetes-
specific social support could act as a ‘buffer’ between antenatal anxiety and postnatal 
depression; women receiving adequate diabetes-specific social support are potentially less 
likely to develop postnatal depression. 
In the wider literature exploring the relationship between diabetes and depression in the 
general population, people living with both diabetes and depression were less likely to report 
receiving needed social support than people with diabetes and no depression (Egede, 
Grubaugh, & Ellis, 2010). A qualitative meta-synthesis examining patients’ experience of 
living with diabetes and depression (Gask, MacDonald & Bower, 2011) found that diabetes 
specific social support from health care professionals, social networks and family members 
could buffer the consequences of living with diabetes or create further difficulties. Social 
support affected self-care behaviours amongst people living with diabetes, with people 
receiving adequate social support being more likely to control their weight and to exercise 
(Bai, Chiou, & Chang, 2009; Rees, Karter, & Young, 2010). At the same time, diabetes 
interference was found to be significantly associated with depressive symptomatology in 
people with type 2 diabetes (Talbot et al., 1999).  
Further research is needed to explore the relationship between diabetes-specific factors and 
postnatal depression. Previous literature showed that individualized diabetes management 
plans (e.g. dietary advice, blood glucose monitoring, insulin therapy-as needed) for pregnant 
women with gestational diabetes reduced the rate of serious perinatal outcomes (such as 
death, shoulder dystocia, bone fracture, nerve palsy), macrosomic babies, and the incidence of 
postnatal depression (Crowther, Hiller, Moss, McPhee, Jeffries, & Robinson, 2005).   
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4.2. Limitations of the study 
The incidence and prevalence rates for postnatal depression that were found in this study 
should be interpreted with caution, as data were collected using participants from a relatively 
small geographical area (i.e. not nationwide data). The present study had a high percentage of 
lost to follow-up participants. The relatively small number of participants could have led to 
the study having insufficient power to detect important associations. Also, there was no 
control group of women without diabetes. A decision was taken not to have a control group, 
due to the small scale of the current student project.  
The study used a self-report measure for the identification of depressive symptoms (i.e. 
EPDS). Although the scale has high sensitivity and specificity (Cox et al., 1987) and its 
psychometric assessment was conducted on a sample of new mothers, it is only a screening 
tool, rather than providing a clinical diagnosis of postnatal depression.  
Diabetes-related distress (i.e. psychosocial adjustment to diabetes, and in particular diabetes-
related emotional distress) was measured using the PAID. Although the scale has good 
psychometric properties and it is widely used when studying diabetes in the general 
population, the PAID is not a specific scale for gestational diabetes. A diagnosis of gestational 
diabetes presents different challenges from type 1 or type 2 diabetes. Women with gestational 
diabetes tend to be worried about the impact it might have on the pregnancy and the baby (i.e. 
stillborn, premature birth, macrosomic babies) and the increased risk for themselves of 
developing diabetes in later life (Hjelm et al., 2005). People living with type 1 and type 2 
diabetes tend to be worried about the development of serious diabetes-related complications, 
such as coronary artery disease, stroke, amputations etc (Miller, 2011). Further research is 
needed for the development and validation of a gestational diabetes-specific scale.  
 79 
No data was collected on diabetes management (i.e. levels of glycaemic control) due to 
unavailability of hospital files. There is a known link between depression and hyperglycaemia 
in people living with type 1 or type 2 diabetes (Lustman, Anderson, Freedland, de Groot, 
Carney, & Clouse, 2000). Langer & Langer (2000) showed that women (with gestational 
diabetes) with well controlled diabetes were significantly less distressed than those with poor 
glycaemic control.  
The strength of the present study lies in the prospective longitudinal investigation of the 
relationship between gestational diabetes and postnatal depression. However, the study did 
not demonstrate that there are diabetes-specific risk factors that predict postnatal depression in 
women with gestational diabetes, over and above known risk factors. Further research using a 
larger sample size is required in order to further investigate the relationship between 
psychosocial variables related to gestational diabetes and postnatal depression.  
The current research project is ongoing. A third hospital in the West Midlands has recently 
joined the study and recruitment has begun in April 2012. We will continue to recruit women 
with gestational diabetes, in order to increase our study sample. At the same time, women 
identified at risk of developing gestational diabetes, but with a negative OGTT test result will 
be recruited and act as a control group for the study.  
4.3. Clinical implications of the study 
The antenatal period is a time when women are highly scrutinized, with a wide range of 
professionals available for consultation. It is an ideal time for women to access support. 
Screening for antenatal depression is important, as the vast majority of women who are 
depressed in the antenatal period continue to be depressed in the postnatal period. Screening 
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for antenatal anxiety is also important, as it is a strong predictor for postnatal depression (as 
well as postnatal anxiety), (Beck, 2001; Coelho et. al., 2011; Robertson et. al., 2004).  
Philipp and Carr (2001) proposed the psychological model of normal pregnancy. They 
suggest that once conception occurs, women pass through three distinct psychological phases. 
They loosely correspond to the three trimesters of pregnancy and are triggered by biological, 
psychological and cultural factors. The first stage (0-18 weeks gestation) is characterized by 
ambivalence about the pregnancy and is dominated by bodily needs (e.g. food) and fear of 
miscarriage. The second stage (18-34 weeks gestation) is the time when fetal movements 
begin to be felt by the expectant mother, and is a time of relative peace. Attachment to the 
fetus takes place in this stage, as illustrated by behaviours such as talking to the fetus, calling 
the fetus a particular pet name etc. The third stage (after 34 weeks gestation) is dominated by 
physical discomfort and the mother’s sense that her fetus is viable (Philipp and Carr, 2001).  
Women are tested for gestational diabetes around 28 weeks, which corresponds with the 
second psychological stage of normal pregnancy. A diagnosis of gestational diabetes means 
that their pregnancy is now considered a high-risk pregnancy, leading to increased levels of 
anxiety about the wellbeing and survival of the fetus. The label of high risk may interfere with 
the process of attachment, in the presence of a threat to the survival of the fetus. The 
knowledge of an ‘imperfect’ pregnancy may affect the mother’s self-esteem, and lead to 
feelings of failure (Philipp and Carr, 2001, p.23).  
Validated questionnaires such as the Hospital Anxiety and Depression Scale (HADS) could 
be used to identify antenatal anxiety and depressive symptoms in women diagnosed with 
gestational diabetes. These women could then be offered additional support from midwives, 
GPs, and mental health services. 
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In line with the NICE guidelines for antenatal and postnatal mental health (NICE, 2007), 
appropriate interventions are needed to support women with gestational diabetes diagnosed 
with antenatal anxiety, including good support for diabetes management. The World Health 
Organisation (WHO) principles of perinatal care stipulate the importance of involving women 
in the decision making process and referral to appropriate education classes, as well providing 
an individualised approach to care at all times (Chalmers, Mangiaterra, & Porter, 2001).  
During the postnatal period (once the baby is born) the support from maternity care 
professionals tends to wind down, and generally becomes limited to several meetings with the 
health visitor. However, health visitors have a remit for ongoing support to women with 
children in the 0-5 age group and therefore are ideally placed to offer more support such as 
listening visits, referral to GP and mental health services. Gestational diabetes could be 
flagged to health visitors, so that they are aware of the increased risk of developing postnatal 
depression. Repeat screening for postnatal depression is recommended, so that women get the 
appropriate help in order to ensure good baby development.  
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Introduction 
Postnatal depression is a common affective disorder following childbirth, affecting around 
13% of women. Studies have shown that postnatal depression tends to affect both the mother 
and her baby, leading to relationship difficulties between the mother and her baby, as well as 
affecting the normal development of the child, particularly for boys from disadvantaged 
backgrounds. Risk factors for postnatal depression include: history of depression, antenatal 
depression, antenatal anxiety, life stress, socioeconomic status, social support, marital 
satisfaction, child care stress, and infant temperament. 
There is a known link between depression and diabetes in the general population. Scientists 
are also interested in the link between diabetes during pregnancy and the mental health of the 
mother around the time of the birth. A large study conducted by Backes Kozhimanhil and 
colleagues in 2009 showed that women with diabetes during pregnancy (gestational diabetes 
and pre-existing diabetes) where almost twice as likely to experience depression as women 
without diabetes.  
Aims of the study 
The study aimed to: 1) establish the percentage of women with gestational diabetes newly 
diagnosed with depression, measured at six weeks postnatal; 2) to establish the total 
percentage of  women who were depressed at six weeks postnatal (including women who 
were depressed in the antenatal period); 3) to investigate whether known risk factors of 
postnatal depression predict depression in women with gestational diabetes; 4) to investigate 
whether diabetes specific risk factors (e.g. diabetes distress, diabetes interference, diabetes 
social support) predict depression in women with gestational diabetes over and above general 
risk factors. 
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Method 
The current study used a longitudinal design, which involved collecting data at two points in 
time. Women with a diagnosis of gestational diabetes who attended a joint antenatal/diabetes 
clinic in the third trimester of pregnancy were invited to participate in the study and asked to 
complete a questionnaire pack. They were followed-up by post at six weeks after childbirth. 
Results 
77 women consented to participate in the study and filled in the questionnaire pack. Out of the 
77 women, 38 also completed the follow-up questionnaire at six weeks following childbirth. 
Overall, 15.8% of women had depressive symptoms; 11.5% of women had not had depressive 
symptoms in the antenatal period. This shows that the majority of women who were 
depressed in the postnatal period were also depressed in the antenatal period.  
Women who had antenatal anxiety were significantly more likely to have postnatal 
depression. Diabetes-specific factors were not significant predictors for postnatal depression. 
Study limitations 
Depressive symptoms were measured using a self-report questionnaire (as opposed to a 
formal medical diagnosis). The analyses were based on a relatively small sample size, and 
therefore important associations were potentially missed. However, the research project is 
ongoing, and we are collecting more data in order to strengthen our results.  
Clinical implications 
It is important to identify women with antenatal depression and anxiety, in order to provide 
them with appropriate care, and potentially reduce the number of women who are newly 
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diagnosed with depression in the postnatal period. Further research is needed to explore the 
role of diabetes-specific factors in the occurrence of postnatal depression in women with 
gestational diabetes.  
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Systematic review –  
Appendix 1 Search flowchart 
 
 
Data sources 
searched 
Citations identified: 333 
 
Titles/abstracts 
screened: 318 
Duplicates removed: 
15 
Full text retrieval: 22 
Full text screened: 24 
Excluded: 296 
 
Other sources: 
Reference lists: 2 
Meeting study inclusion 
criteria: 10 
Excluded: 14 
 
Medline: 187 
PsycINFO: 34 
Embase: 112 
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Appendix 2 Selected characteristics of included studies 
Study Design No of participants Age at 
baseline 
mean±SD 
(range) & 
Gender      
(% male) 
Type of 
diabetes/  
Duration 
mean±SD 
(range) 
Length 
of 
follow 
up 
(years) 
Depression 
assessment 
method 
Diabetes 
assessment 
method 
Complications: 
assessment 
method 
Results  
Baseline   Follow up 
USA: 
Orchard et 
al, 2003 
Prospective 
cohort study 
603                   600  
Angina:  
49 (8.1%) 
ECG Ischemia:  
17 (2.8%) 
Hard CAD:  
42 (6.9%) 
Total CAD:  
108 (17.7%)         
28 (8-47) 
years old 
51% men 
Type 1 
19 (7-37) 
10 BDI>14 
(≥18 years of 
age) 
Medical 
records 
ECG ischemia: 
Minnesota Code; 
Angina: Pittsburgh 
EDC study physician 
diagnosis;       Hard 
CAD: angiographic 
stenosis ≥ 50%; 
revascularisation 
procedure; Q 
waves (MC 1.1-1.2), 
nonfatal MI or CAD 
death 
Depressive symptoms 
predicted angina  
HR=1.40                     
95% CI=1.06-1.84  
p<0.05 
Depressive symptoms 
did not predict hard 
CAD events (e.g. 
myocardial infarction) 
or total CAD. 
USA: Black 
et al, 2003 
Prospective 
population 
study 
2830               2092 
DM:                  DM:  
636                   453 
(22.5%)      (21.7%)         
65+ years 
old 
41.4% men 
Type 2 7 
 
CESD>16 at 
baseline and 
CIDI/DSM-IV 
at  2-year 
follow up 
Self-report Nephropathy, 
retinopathy, 
neuropathy 
(microvascular): 
self-report. 
CAD, stroke, kidney 
disease 
(macrovascular)- 
Depressive symptoms 
predicted:   
1) microvascular 
complications:         
HR=8.63                
95%CI=5.40-13.79 
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Study Design No of participants Age at 
baseline 
mean±SD 
(range) & 
Gender      
(% male) 
Type of 
diabetes/  
Duration 
mean±SD 
(range) 
Length 
of 
follow 
up 
(years) 
Depression 
assessment 
method 
Diabetes 
assessment 
method 
Complications: 
assessment 
method 
Results  
Baseline   Follow up 
self-report. 2) macrovascular 
complications: 
HR=2.40          
95%CI=1.71-3.36 
Lifetime depression 
predicted: 
a) microvascular 
complications: 
HR=11.32              
95%CI=8.76-15.43 
b) macrovascular 
complications:     
HR=2.64    95%CI=1.73-
4.04 
p<0.05 
Australia: 
Bruce et 
al, 2005 
Prospective 
observational 
study 
1273    369 deaths                          
           152 cardiac        
deaths                                                                                            
64.1 (52-73) 
years old 
48.7% men 
Type 2 
4 (1-9) 
7.8±2.4 GHS (presence 
of two or 
more 
symptoms 
was seen as 
indicative of 
Fasting blood 
glucose levels 
Peripheral sensory 
neuropathy: 
Michigan 
Neuropathy 
Screening 
Depressive symptoms 
did not predict CHD 
mortality after 
adjustment for 
diabetes 
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Study Design No of participants Age at 
baseline 
mean±SD 
(range) & 
Gender      
(% male) 
Type of 
diabetes/  
Duration 
mean±SD 
(range) 
Length 
of 
follow 
up 
(years) 
Depression 
assessment 
method 
Diabetes 
assessment 
method 
Complications: 
assessment 
method 
Results  
Baseline   Follow up 
depression) Instrument 
Retinopathy: direct 
and/or indirect 
ophthalmoscopy  
CVD: self-reported 
stroke or TIA 
CHD: self-
reported/hospital 
history of MI, 
angina, coronary 
artery bypass 
grafting, 
angioplasty 
PAD: ABI≤0.9. or 
the presence of a 
diabetes-related 
amputation 
complications: 
HR=1.15      
95%CI=0.80-1.68  
P=0.45 
 
USA:   Roy, 
Peng & 
Roy, 2007 
Prospective 
cohort study 
725                   483 27.5±10.8 
years old 
40.4% men 
Type 1 
10.4±8.6 
6.1±0.5 BDI>14 Medical 
records 
CAD: medical 
records 
Stroke: medical 
records 
Peripheral 
Depressive symptoms 
predicted incidence of 
any CVD (CAD or 
stroke) 
OR=1.04   
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Study Design No of participants Age at 
baseline 
mean±SD 
(range) & 
Gender      
(% male) 
Type of 
diabetes/  
Duration 
mean±SD 
(range) 
Length 
of 
follow 
up 
(years) 
Depression 
assessment 
method 
Diabetes 
assessment 
method 
Complications: 
assessment 
method 
Results  
Baseline   Follow up 
neuropathy: self-
report 
Retinopathy: Airlie 
House classification 
of diabetic 
retinopathy 
95%CI=1.001-1.08 
p<0.05 
 
USA:  Roy, 
Roy & 
Affouf, 
2007 
Prospective 
cohort study 
725                   483 27.5±10.8 
years old 
40.4% men 
Type 1 6.1±0.5 BDI>14 Medical 
records 
Retinopathy: Airlie 
House classification 
of diabetic 
retinopathy 
Depressive symptoms 
predicted:   
1) Diabetic retinopathy 
(DR):  
OR=2.44         
95%CI=1.01-5.88 
2) Proliferative DR:  
OR=3.19 
95%CI=1.30-7.87 
p<0.05 
USA: 
Katon et 
Prospective 
cohort study 
4239               2909 55.1% > 60 
years of age 
Type 1 – 
4.8%  
5 PHQ-9 for 
baseline and 
follow-up 
Medical 
records 
Medical records  
(ICD-9 diagnosis 
1) Retinopathy did not 
predict depression: 
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Study Design No of participants Age at 
baseline 
mean±SD 
(range) & 
Gender      
(% male) 
Type of 
diabetes/  
Duration 
mean±SD 
(range) 
Length 
of 
follow 
up 
(years) 
Depression 
assessment 
method 
Diabetes 
assessment 
method 
Complications: 
assessment 
method 
Results  
Baseline   Follow up 
al, 2009 
 
50.8% men Type 2 – 
95.2% 
9±6 
depression 
ICD-9 codes 
for history of 
depression 
(ICD-9 
diagnosis 
codes) 
codes and CPT 
codes) 
OR=0.69 
CI=0.40-1.21 
p>0.05 
2) Nephropathy did not 
predict depression: 
OR=1.06 
CI=0.65-1.71 
P>0.05 
3) number of 
microvascular events 
did not predict 
depression: 
OR=0.88 
CI=0.64-1.21 
p>0.05 
 
4) number of 
macrovascular events 
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Study Design No of participants Age at 
baseline 
mean±SD 
(range) & 
Gender      
(% male) 
Type of 
diabetes/  
Duration 
mean±SD 
(range) 
Length 
of 
follow 
up 
(years) 
Depression 
assessment 
method 
Diabetes 
assessment 
method 
Complications: 
assessment 
method 
Results  
Baseline   Follow up 
or procedures 
predicted depression: 
OR=1.39 
95%CI=1.02-1.88 
p<0.05 
5) Coronary 
procedures predicted 
depression: 
OR=1.92 
95%CI=1.14-3.25 
p<0.05 
USA: 
Vileikyte 
et al, 2009 
Prospective 
cohort study 
Baseline: 495 
9 months: 376 
18 months: 338 
61.87±11.01 
years old 
70.7% men 
Type 1 
(27%) or 
Type 2 
(73%) 
 
1.5  HADS N/A Neuropathy: 
DPN severity: 
VPT>25 V 
NDS>3 
DPN somatic 
experiences 
(symptoms and 
Increased depression 
scores were predicted 
by: 
1) Baseline NDS 
β=0.10, p<0.05 
2) baseline 
unsteadiness 
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Study Design No of participants Age at 
baseline 
mean±SD 
(range) & 
Gender      
(% male) 
Type of 
diabetes/  
Duration 
mean±SD 
(range) 
Length 
of 
follow 
up 
(years) 
Depression 
assessment 
method 
Diabetes 
assessment 
method 
Complications: 
assessment 
method 
Results  
Baseline   Follow up 
foot ulceration): 
NeuroQoL 
DPN psychological 
consequences 
(restrictions in ADL 
and social self-
perception): 
NeuroQoL 
β=0.16, p<0.01 
3) baseline ADL 
restrictions 
β=0.16, p<0.01 
4) changes in social 
self-perception 
β=0.13, p<0.01 
USA: 
Gonzales 
et al, 2010 
Prospective 
cohort study 
Baseline: 333 
During follow up 63 
participants 
developed foot ulcers 
62.2±11.1 
years old 
70.6% men 
Type 1 
(27%) or 
Type 2 
(73%) 
17.0±11.5 
1.5 HADS N/A Neuropathy: 
VPT≥25 V 
NDS≥3 
Foot ulcers: self-
report 
Depressive symptoms 
predicted first foot 
ulcers 
HR=1.68  
95% CI=1.20-2.35 
USA: 
Lin et al, 
2010 
Prospective 
cohort study 
4623            3723 64.3±12.5 
years old 
52.1% men 
Type 2 
8.8±8.4 
5 PHQ-9 Medical 
records 
ICD-9 
diagnosis 
codes 
Medical records 
ICD-9 diagnosis 
codes 
Major depression 
predicted: 
1) microvascular 
complications 
HR=1.36 
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Study Design No of participants Age at 
baseline 
mean±SD 
(range) & 
Gender      
(% male) 
Type of 
diabetes/  
Duration 
mean±SD 
(range) 
Length 
of 
follow 
up 
(years) 
Depression 
assessment 
method 
Diabetes 
assessment 
method 
Complications: 
assessment 
method 
Results  
Baseline   Follow up 
95% CI=1.05-1.76 
2) macrovascular  
complications 
HR=1.25 
95%CI=1.00-1.54 
P<0.05 
USA: 
Sieu et al, 
2011 
Prospective 
cohort study 
2359            2355 63.9±12.9 
years old 
52.2% men 
Type 2 
8.1±8.1 
5 PHQ-9 Medical 
records 
(ICD-9 
diagnosis 
codes) 
Medical records 
(ICD-9 diagnosis 
codes) 
Depressive symptoms 
predicted an increased 
risk of incident 
retinopathy 
OR=1.026 
95%CI=1.002-1.051 
P<0.05 
Depressive symptoms 
were associated with 
time to incident 
retinopathy 
HR=1.025 
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Study Design No of participants Age at 
baseline 
mean±SD 
(range) & 
Gender      
(% male) 
Type of 
diabetes/  
Duration 
mean±SD 
(range) 
Length 
of 
follow 
up 
(years) 
Depression 
assessment 
method 
Diabetes 
assessment 
method 
Complications: 
assessment 
method 
Results  
Baseline   Follow up 
95%CI=1.009-1.041 
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Acronyms  
ABI = Ankle brachial index 
ADL = activities of daily living 
BDI= Beck Depression Inventory 
CAD= Coronary artery disease 
CESD = Centre for Epidemiologic Studies Depression Scale 
CHD = coronary heart disease 
CI = Confidence interval 
CIDI/DSM-IV = Composite International Diagnostic Interview / Diagnostic and Statistical Manual of Mental Disorders, 4th edition 
CPT codes = Current Procedural Terminology Codes 
CVD = cerebrovascular disease 
DN = diabetic neuropathy 
DN-DA = diabetic neuropathy with co-morbid depression or anxiety 
DPN = diabetic peripheral neuropathy 
DR = diabetic retinopathy 
EDC = Epidemiology of diabetes complications 
GHS = General Health status questionnaire 
HADS = Hospital Anxiety and Depression Scale 
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HR = Hazard ratio 
ICD-9 = International Classification of Diseases, 9th Revision 
N/A = not available 
MI = Myocardial Infarction  
NDS = neuropathy disability score 
NeuroQoL = Neuropathy and Foot Ulcer-specific Quality of Life Instrument 
PAD = peripheral arterial disease 
PHQ-9 = Patient Health Questionnaire – 9  
OR = Odds ratio 
TIA = Transient ischaemic attack 
VPT = vibration perception threshold 
Mood States and Diabetes in Pregnancy study. Participants Invitation Letter v1 / 02.08.10 
 
[Enter Date] 
 
Mood States and Diabetes in Pregnancy study 
 
 
Dear [enter Name] 
 
Researchers from the University of Birmingham and health care professionals at 
Warwick Hospital and University Hospital, Coventry are working together to try to 
develop ways to help mothers experiencing gestational diabetes.  
 
We have enclosed an Information Sheet, which provides further details about the 
study and what taking part would involve.   
 
We would like to invite you to take part in the research. If you agreed to take part, any 
information that you provided to the researcher would be treated as strictly 
confidential, and your identity would not be revealed to anybody outside the study.  
 
We will contact you in one week to find out whether you have any further questions, 
and to hear your decision about whether you wish to take part. If you agreed to take 
part, we would ask you to sign one copy of the enclosed consent forms and return it to 
us in the reply prepaid envelope. The second consent form would be for you to keep. If 
you decided that you did not wish to take part you could tell the researcher when she 
contacted you.   
 
Whether or not you decide to take part we would like to thank you for taking the time 
to find out more about the research study. 
 
 
With best wishes 
 
 
Dr. Isabela Caramlau 
Study researcher 
School of Psychology 
University of Birmingham 
Edgbaston, Birmingham 
B15 2TT 
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Appendix 3 Quality assessment of included studies 
Study 
Choice of 
outcome 
measure 
(depression 
only) 
Description of 
study 
population 
Control for 
confounding 
variables (age, 
gender, SES, 
education) 
Blinding of 
baseline 
assessment data 
- diabetes 
diagnosis only 
Description of 
follow-up 
numbers 
Description of 
drop-out rates 
Comparison of 
drop-out rates on 
key variables 
Sufficient 
follow-up 
period 
Orchard et 
al, 2003 
Adequate Adequate Adequate N/A Adequate Inadequate  Inadequate  Adequate 
Black et al, 
2003 
Adequate  Adequate  Adequate  Not reported Adequate Inadequate  Inadequate  Adequate 
Bruce et 
al, 2005 
Inadequate  Adequate  Adequate  N/A Adequate  Inadequate  Inadequate  Adequate 
Roy, Peng 
& Roy, 
2007 
Adequate Adequate  Inadequate  N/A Adequate  Adequate  Inadequate  Adequate 
Roy, Roy & 
Affouf, 
2007 
Adequate Adequate Adequate N/A Adequate Adequate Inadequate Adequate 
Katon et 
al, 2009 
Adequate  Adequate Adequate N/A Adequate Adequate Adequate Adequate 
Vileikyte 
et al, 2009 
 
Adequate Adequate Adequate N/A Adequate Adequate Adequate  Inadequate 
Gonzales 
et al, 2010 
Adequate Adequate Inadequate  N/A Inadequate  Inadequate Inadequate Inadequate 
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Study 
Choice of 
outcome 
measure 
(depression 
only) 
Description of 
study 
population 
Control for 
confounding 
variables (age, 
gender, SES, 
education) 
Blinding of 
baseline 
assessment data 
- diabetes 
diagnosis only 
Description of 
follow-up 
numbers 
Description of 
drop-out rates 
Comparison of 
drop-out rates on 
key variables 
Sufficient 
follow-up 
period 
Lin et al, 
2010 
Adequate Adequate Adequate N/A Adequate Adequate Inadequate  Adequate 
Sieu et al, 
2011 
Adequate Adequate Adequate N/A Adequate Adequate Inadequate Adequate 
 
N/A = not applicable; SES = socioeconomic status 
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Study Title: Mood states and diabetes in pregnancy 
Participant Information Sheet 
 
 
 
 
Research Ethics Committee reference numbe  
 
 
We are inviting you to take part in a research study, which is being undertaken as part 
of a clinical psychology training programme. 
 
Before you decide whether you want to take part, it is important for you to 
understand why the research is being done, and what it will involve. We would be 
grateful if you could take the time to read the following information carefully. Please 
feel free to discuss it with friends, relatives, midwife and your family doctor (GP) if 
you wish. If there is anything that is not clear, or if you would like more information, 
please contact the study researcher, Isabela Caramlau, whose contact details you will 
find at the end of this information sheet.   
 
We would be grateful if you were able to take a decision within the next week. 
 
What is the purpose of the study? 
 
The aim of this study is to investigate the occurrence of postnatal depression (PND) 
and identify factors that may increase the risk for developing PND among women with 
diabetes in pregnancy. Specifically, we aim to investigate: i) whether known risk 
factors of PND predict depression in women with gestational diabetes; ii) whether 
diabetes specific risk factors (e.g. problems with diabetes control, management, etc.) 
predict depression in women with gestational diabetes over and above general risk 
factors. 
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Why have I been selected to take part in the study? 
 
All women who have been invited to undergo a glucose tolerance test during pregnancy 
will be invited to participate in the study.  
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part.  This information sheet is 
provided to help you to make that decision. Even if you decided to take part, you would 
still be free to withdraw at any time and would not have to give a reason.  This would 
not affect the care you receive.   
 
What would taking part in the study involve? 
 
If you agree to take part in the study, you will be asked to fill in a questionnaire pack 
at three different points in time: 3rd trimester of your pregnancy, 6 weeks postnatal 
and 3 months postnatal. The questionnaires will take about 45 minutes to complete. 
You could do this while at the hospital for tests or when seeing the doctor/midwife. 
The follow-up questionnaires will be posted to you. If we do not hear from you, we will 
send you a reminder letter, followed by a phone call. 
We would also like to have access to your medical records in order to find information 
about your pregnancy and outcome, height, weight, and blood glucose diary.  
 
Any information you provided would be treated as confidential and anonymous. Your 
participation in this study would not affect any support or care that you were 
receiving. 
 
Who would know about me taking part in the study? 
 
The research team would know whether you had agreed to take part in the study. We 
would also like to let your GP and your midwife know that you are taking part. Should 
you prefer that this information remains confidential, please let us know.  
When writing up the findings of the study the researchers would take care to ensure 
that they did not reveal the identity of participants. All information that you provide 
to us will be treated as confidential and will not be shared with anyone outside the 
research team unless required by law under the terms of the Children Act (1989).  
This refers to any information about risk to a child that is brought to the attention of 
a researcher.   
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What are the benefits of taking part? 
 
The study could lead to the early identification of emotional distress. If you require 
professional help, we will discuss this with you first and suggest that you contact your 
GP for treatment and support. It could also have a significant impact on the wellbeing 
of the baby, by improving your mental health and functioning. It might also help to 
improve and refine the NHS service for future mothers.   
 
What are the possible disadvantages and risks of taking part? 
 
There are no risks involved. However, if you become distressed as a result of your 
participation, please let us know using the contact details below. In the first instance 
we will discuss the difficulties that arose. If you require professional help, we will 
discuss this with you first and suggest that you contact your GP.   
 
If the answers that you give to the well-being questionnaires cause us concern about 
your well-being, we will contact you and may suggest that you contact your GP or your 
diabetes care providers for further advice.  
 
What if something goes wrong? 
 
Once again, if participating in this research project distresses you, you should let us 
know by using the contact information at the end of this sheet.  In the first instance, 
we will discuss your difficulties with you.  If you need professional help, we will speak 
to you about this and you may then want to contact your GP or Doctor at clinic.   
Contact for complaints: 
Dr Jan Oyebode 
ClinPsyD course director  
Faculty of Psychology 
University of Birmingham 
Edgbaston, Birmingham 
B15 2TT 
Tel: 0121 4147124 
 
There are no special compensation arrangements.  If you are harmed due to someone’s negligence, 
then you may have grounds for a legal action but you may have to pay for it.  Regardless of this, if 
you wish to complain, or have any concerns about any aspect of the way you have been approached or 
treated during the course of this study, the normal National Health Service complaints mechanisms 
should be available to you. 
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What if I have special needs? 
 
We will make every effort to ensure that there are no barriers for you if you wish to 
take part. If you have communication problems due to a disability – e.g. hearing 
impairment / visual impairment/ dyslexia, you are asked to contact us using the details 
below. If you have difficulties with reading, please inform us. The researcher may be 
able to offer you more time to complete the study and will assist you in reading the 
questionnaires. If you can think of any other difficulties, please contact the 
researcher and every effort will be made to make things easier for you. 
 
What would happen to the information I provide in the questionnaires? 
 
The questionnaires will be stored in a locked cabinet and would only be identifiable via 
the study number.  The responses would only be used for the purposes of this study, 
and would be destroyed after a period of five years.  
 
What will happen to the results of the research study? 
 
The results of the study will be written up in a final report and the results may also be 
written up in professional journals. If you are interested, we will be happy to provide 
you with a copy of the report. All participants’ information will be completely 
anonymised and no-one will be able to identify you from the report or article. 
 
Who is organising and funding the research? 
 
Researchers from Birmingham University together with midwives and diabetes 
specialist nurses from Warwick Hospital, University Hospital, Coventry, and 
Birmingham Women’s Hospital are organising and conducting the study.  The study is 
being conducted under the direction of Dr Arie Nouwen, Senior Lecturer at the 
University of Birmingham and Dr Kirstie McKenzie-McHarg, Clinical Psychologist at 
Warwick Hospital.  The study researcher is Dr. Isabela Caramlau. 
 
Who has reviewed the study? 
 
The study has been reviewed and approved by the NHS Research Ethics Committee. 
 
What if I want further information about the study? 
 
If you want any further information about the study you can contact the study 
researcher Isabela Caramlau at IOC913@bham.ac.uk. 
 
*  *  *  *  *  * 
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Mood States and Diabetes in Pregnancy Research Study 
______________________________________________________ 
 
 
 
Research Ethics committee number  
 
Consent form for research participants 
 
(Please tick each box)  
 
1. I confirm that I have read and understood the information sheet for the above 
study. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily. 
 
2. I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time during the research, without giving any reason, and without my 
care being affected.   
 
3. I understand that the information which I provide will be treated in confidence 
and that it will not be shared with any person outside of the research team.    
 
4. I give permission for my medical records to be accessed by the research team   
5. I confirm that I am willing to take part in this research study  
 
 
 
................................  ...................  ...................................... 
Name of participant  Date   Signature 
 
...............................  ...................  ...................................... 
Name of researcher  Date   Signature 
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Study Title: Mood states and  
diabetes in pregnancy 
 
 
 
Dear [Name] 
 
 
A few weeks ago you have kindly agreed to take part in the Mood States and Diabetes 
in Pregnancy research study. 
 
The aim of this study is to investigate the occurrence of postnatal depression (PND) 
and identify factors that may increase the risk for developing PND among women with 
diabetes in pregnancy.  
 
We enclose the 1st follow up questionnaire pack. We would be grateful if you could 
complete and return the questionnaire pack within the next two weeks. 
 
Should you require further information or assistance with completing the 
questionnaire pack, please do not hesitate to contact me. 
 
Your contribution to the success of this study will be greatly appreciated.  
 
Yours sincerely 
 
Dr. Isabela Caramlau 
Study researcher 
School of Psychology 
University of Birmingham 
Edgbaston, Birmingham 
B15 2TT 
 
 
 
 
 
 
 
 
 
Please read the following information before you answer the questions: 
 
 
A: Instructions 
 
1. This questionnaire is divided into 8 sections, labelled Form 1-8. 
2. Please answer all of the questions in each section in the order they 
appear in the questionnaire. 
3. There are no ‘right’ or ‘wrong’ answers, so please answer the questions 
as honestly as you can. 
4. Please read the instructions at the beginning of each section and circle 
the response which you feel is the most relevant to you. 
5. Although some statements may seem similar to others, no two are 
exactly the same. 
6. Please take your time to read and understand the questions thoroughly.  
7. If there is anything you do not understand, please ask the researcher for 
help. 
 
 
B: Confidentiality 
 
1. Your name will not be put on the questionnaire. The researchers have 
given each questionnaire a code number, known only to them. 
2. All information stored on computer is compliant with the Data Protection 
Act. 
3. The information you provide in this questionnaire is confidential and will 
not be shared with anyone outside the research team unless required by 
law under the terms of the Children’s Act (1989). 
 
 
If you have any queries please contact: 
Isabela Caramlau on  
 
Questionnaire type: BD 
 
Date of receipt……………    Participant no……………. 
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 Tick one 
Marital Status  
1. Single [   ] 
2. Married/cohabiting [   ] 
3. Separated [   ] 
4. Divorced [   ] 
5. Widowed [   ] 
6. Partnered [   ] 
 
 
 
Socioeconomic Status  
Low  [   ] 
Middle [   ] 
High  [   ] 
 
 
 
Self-esteem Yes No 
Do you feel good about yourself as a person? [   ] [   ] 
Do you feel worthwhile? [   ] [   ] 
Do you feel you have a number of good qualities as a 
person? 
[   ] [   ] 
 
 
 
Prenatal Depression Yes No 
1. Have you ever felt depressed during your 
pregnancy? 
[   ] [   ] 
If yes, when and how long have you been feeling this 
way? 
 
If yes, how mild or severe would you consider your 
depression? 
 
 
 
 
Prenatal Anxiety Yes No 
1. Have you ever felt anxious during your pregnancy? [   ] [   ] 
If yes, how long have you been feeling this way?  
 
 
  
Views on pregnancy Yes No 
Was the pregnancy planned? [   ] [   ] 
Is the pregnancy wanted? [   ] [   ] 
Form 1 
 
Please place a tick in the column that describes you best: 
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History of previous depression Yes No 
1. Before this pregnancy, have you ever been 
depressed? 
[   ] [   ] 
If yes, when did you experience this depression?   
If yes, have you been under a GP’s care for this past 
depression 
  
If yes, did the GP prescribe any medication for your 
depression? 
  
 
 
  
Social Support Yes No 
1. Do you feel you receive adequate support from 
your partner? 
[   ] [   ] 
2. Do you feel you receive adequate practical support 
from your partner? (e.g. help with household chores 
or babysitting) 
[   ] [   ] 
3. Do you feel you can rely on your partner when you 
need help? 
[   ] [   ] 
4. Do you feel you can confide in your partner? [   ] [   ] 
   
1. Do you feel you receive adequate support from 
your family? 
[   ] [   ] 
2. Do you feel you receive adequate practical support 
from your family? (e.g. help with household chores or 
babysitting) 
[   ] [   ] 
3. Do you feel you can rely on your family when you 
need help? 
[   ] [   ] 
4. Do you feel you can confide in your family? [   ] [   ] 
   
1. Do you feel you receive adequate support from 
your friends? 
[   ] [   ] 
2. Do you feel you receive adequate practical support 
from your friends? (e.g. help with household chores 
or babysitting) 
[   ] [   ] 
3. Do you feel you can rely on your friends when you 
need help? 
[   ] [   ] 
4. Do you feel you can confide in your friends? [   ] [   ] 
 
 
  
Marital Satisfaction Yes No 
1. Are you satisfied with your marriage (or living 
arrangements)? 
[   ] [   ] 
2. Are you currently experiencing any marital 
problems? 
[   ] [   ] 
3. Are things going well between you and your 
partner? 
[   ] [   ] 
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Life stress Yes  No 
1. Are you currently experiencing any stressful events 
in your life such as: 
  
• Financial problems [   ] [   ] 
• Marital problems [   ] [   ] 
• Death in the family [   ] [   ] 
• Serious illness in the family [   ] [   ] 
• Moving  [   ] [   ] 
• Unemployment  [   ] [   ] 
• Job change [   ] [   ] 
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1. I am confident of having a normal childbirth  
2. I think my labour and delivery will go normally  
3. I have a lot of fear regarding the health of my baby  
4. I am worried that the baby could be abnormal    
5. I am afraid that I will be harmed during delivery  
6. I am concerned (worried) about how the baby is growing and 
developing inside me  
 
7. I am concerned (worried) about losing the baby  
8. I am concerned (worried) about having a hard or difficult labour 
and delivery  
 
9. I am concerned (worried) about taking care of a new baby  
10. I am concerned (worried) about developing medical problems 
during my pregnancy 
 
Form 2 
 
For each question, please write the number that best describes how you feel: 
1 – Not at all or never    3 – Moderately or most of the time 
2 – Somewhat or sometimes   4 – Very much or almost all the time 
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 Yes 
definitely 
Yes 
sometimes 
No, not 
much 
No, not  
at all 
1. I wake early and then sleep 
badly for the rest of the night. 
 
    
2. I get very frightened or 
have panic feelings for 
apparently no reason at all. 
 
    
3. I feel miserable and sad. 
 
    
4. I feel anxious when I go 
out of the house on my own. 
 
    
5. I have lost interest in 
things. 
 
    
6. I get palpitations, or 
sensations of ‘butterflies’ in 
my stomach or chest. 
    
7. I have a good appetite. 
 
    
8. I feel scared or frightened. 
 
    
9. I feel life is not worth 
living. 
 
    
10. I still enjoy the things I 
used to. 
 
    
11. I am restless and can’t 
keep still. 
    
12. I am more irritable than 
usual. 
    
13. I feel as if I have slowed 
down. 
    
14. Worrying thoughts 
constantly go through my 
mind. 
    
Form 3 
 
Please place a tick in the column that describes you best: 
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Over the last two weeks 
All of the 
time 
5 
Most of 
the time 
4 
More than 
half of the 
time 
3 
Less than 
half of 
the time 
2 
Some of 
the time 
1 
At no time 
0 
1. I have felt cheerful and 
in good spirits 
      
2. I have felt calm and 
relaxed 
      
3. I have felt active and 
vigorous 
      
4. I woke up feeling fresh 
and rested 
      
5. My daily life has been 
filled with things that 
interest me 
      
Form 4 
 
Please indicate for each of the five statements which is closest to how you have been 
feeling over the last two weeks. Notice that higher numbers mean better well-being. 
 
Example: If you have felt cheerful and in good spirits more than half of the time 
during the last two weeks, put a tick in the box with the number 3. 
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A. Have you been able to talk about your feelings and problems with at least one friend 
during the last month? 
 
1. I could always talk freely about my feelings 
2. I usually could talk about my feelings 
3. About half the time I felt able to talk about my feelings 
4. I usually was not able to talk about my feelings 
5. I was never able to talk about my feelings 
 
 
 
B. Have you been able to talk about your feelings and problems with at least one of 
your relatives in the last month? 
 
1. I could always talk freely about my feelings 
2. I usually could talk about my feelings 
3. About half the time I felt able to talk about my feelings 
4. I usually was not able to talk about my feelings 
5. I was never able to talk about my feelings 
 
 
 
C. Have you been able to talk about your feelings and problems with your spouse or 
partner in the last month? 
 
1. I could always talk freely about my feelings 
2. I usually could talk about my feelings 
3. About half the time I felt able to talk about my feelings 
4. I usually was not able to talk about my feelings 
5. I was never able to talk about my feelings 
 
 
 
 
 
 
 
 
 
Form 5 
 
For each question, please circle the number that best describes you: 
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 Not a problem 
Minor 
problem 
Moderate 
problem 
Somewhat 
serious 
problem 
Serious 
problem 
1. Not having clear and concrete goals 
for your diabetes care 0 1 2 3 4 
2. Feeling discouraged with your 
diabetes treatment plan 0 1 2 3 4 
3. Feeling scared when you think 
about living with diabetes 0 1 2 3 4 
4. Uncomfortable social situations 
related to your diabetes care  
(e.g. people telling you what to eat)? 
0 1 2 3 4 
5. Feelings of deprivation regarding 
food and meals 0 1 2 3 4 
6. Feeling depressed when you think 
about living with diabetes 0 1 2 3 4 
7. Not knowing if your mood or 
feelings are related to your diabetes 0 1 2 3 4 
8. Feeling overwhelmed by your 
diabetes 0 1 2 3 4 
9. Worrying about low blood sugar 
reactions 0 1 2 3 4 
10. Feeling angry when you think 
about living with diabetes 0 1 2 3 4 
11. Feeling constantly concerned 
about food and eating 0 1 2 3 4 
 
12. Worrying about the future and the 
possibility of serious complications 
 
0 1 2 3 4 
Form 6 
 
Which of the following diabetes issues are currently a problem for you? 
 
Circle the number that gives the best answer for you. Please provide an 
answer for each question.  
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Not a 
problem 
Minor 
problem 
Moderate 
problem 
Somewhat 
serious 
problem 
Serious 
problem 
13. Feelings of guilt or anxiety when 
you get off track with your diabetes 
management 
0 1 2 3 4 
14. Not "accepting" your diabetes 0 1 2 3 4 
15. Feeling unsatisfied with your 
diabetes physician 0 1 2 3 4 
16. Feeling that diabetes is taking up 
too much of your mental and physical 
energy every day 
0 1 2 3 4 
17. Feeling alone with your diabetes 0 1 2 3 4 
18. Feeling that your friends and 
family are not supportive of your 
diabetes management efforts 
0 1 2 3 4 
19. Coping with complications of 
diabetes 0 1 2 3 4 
20. Feeling "burned out" by the 
constant effort needed to manage 
diabetes 
0 1 2 3 4 
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Section I: For each question please circle the number that corresponds best to your 
situation  
                                                                         
                                                                         Not at all                                                            Extremely 
1. To what extent does your diabetes 
interfere with your daily activities? 0 1 2 3 4 
 
5 
 
6 
2. To what extent does your partner support 
you with your diabetes?    
(______Tick here you live alone) 
0 1 2 3 4 
 
5 
 
6 
3. To what extent do you consider your 
diabetes to be a severe health problem? 0 1 2 3 4 
 
5 
 
6 
4. To what extent does your diabetes 
decrease your satisfaction or pleasure from 
social or recreational activities? 
0 1 2 3 4 
 
5 
 
6 
5. To what extent do your family and friends 
support you or help with your diabetes? 0 1 2 3 4 
 
5 
 
6 
6. To what extent do you worry about long-
term complications of diabetes? 0 1 2 3 4 
 
5 
 
6 
7. To what extent does your diabetes 
interfere with your effectiveness at work? 0 1 2 3 4 
 
5 
 
6 
8. To what extent does your diabetes 
interfere with your relationship with your 
partner?  
(______Tick here if you live alone) 
0 1 2 3 4 
 
5 
 
6 
9. To what extent do you worry about your 
diabetes? 0 1 2 3 4 
 
5 
 
6 
10. To what extent does your partner pay 
attention to you because of your diabetes? 
(______Tick here if you live alone) 
0 1 2 3 4 
 
5 
 
6 
11. To what extent does your diabetes 
prevent you from traveling as much as you 
would like? 
0 1 2 3 4 
 
5 
 
6 
12. To what extent does your doctor or 
health care team support you or help you 
with your diabetes? 
0 1 2 3 4 
 
5 
 
6 
13. To what extent does your diabetes 
interfere with your ability to participate in 
social or recreational activities? 
0 1 2 3 4 
 
5 
 
6 
Form 7 
 
We are interested to learn more about your diabetes and the way it affects 
your life. 
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14. To what extent does your diabetes 
interfere with your ability to plan your 
activities? 
0 1 2 3 4 
 
5 
 
6 
15. To what extent does your diabetes 
prevent you from being as active as you 
would like? 
0 1 2 3 4 
 
5 
 
6 
16. To what extent does your diabetes 
prevent you from having a schedule that 
you like (e.g. to sleep late)? 
0 1 2 3 4 
 
5 
 
6 
Section II: We are interested to learn about the way your partner responds to you 
concerning your self-care program.  For each question please circle the number 
that best indicates how often they respond to you in that particular way. 
                                                                                                                                                                   Very 
My partner:                                                              Never                                                                       often                                                           
  1. Congratulates me when I follow my diet 0 1 2 3 4 
 
5 
 
6 
2. Hassles me about my diabetes 
medication (pills, insulin)  
(______Tick here if you do not take 
medication for your diabetes) 
0 1 2 3 4 5 6 
3. Congratulates me for regularly measuring 
my blood glucose level.  
(______Tick here if self-monitoring of blood 
sugar levels has NOT been recommended) 
0 1 2 3 4 5 6 
4. Hassles me about exercise. 
(______Tick here if you have been advised 
NOT to exercise) 
0 1 2 3 4 
 
5 
 
6 
5. Reminds me to take care of my feet.  
(______Tick here if foot care has not been 
recommended) 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
6. Congratulates me when I follow my meal 
schedule (meals and snacks). 0 1 2 3 4 
 
5 
 
6 
7. Reminds me to take my diabetes 
medication (pills, insulin) 
(______ Tick here if you do NOT take 
medication for your diabetes). 
0 1 2 3 4 5 6 
8. Helps me to adjust my food intake when I 
exercise. 
(______ Tick here if you have been advised 
NOT to exercise). 
0 1 2 3 4 5 6 
9. Hassles me about my diet. 0 1 2 3 4 5 6 
10. Plans family activities in a way that 
allows me to take my medication at the right 
time. 
(______ Tick here if you do NOT take 
medication for your diabetes) 
0 1 2 3 4 5 6 
11. Hassles me about measuring my blood 
sugar. 
(______Tick here if self-monitoring of blood 
sugar levels has NOT been recommended) 
0 1 2 3 4 5 6 
12 
 
12. Encourages me to exercise. 
(______ Tick here if you have been advised 
NOT to exercise) 
0 1 2 3 4 5 6 
Section III: Treatment of diabetes involves several self-care activities (e.g. diet, 
exercise etc.). People sometimes find it difficult, or do not see the importance of 
following one or more of these self-care activities.  We would like to know how this 
applies to you.  Read each question carefully and circle the number that 
corresponds best to your situation.   
 
                                                                            
                                                             
1. How confident are you in your ability to 
follow your diet. 
 
0 1 2 3 4 
 
5 
 
6 
2. How confident are you in your ability to 
test your blood sugar at the recommended 
frequency? 
(______ Tick here if measuring of blood 
sugar levels has NOT been recommended) 
0 1 2 3 4 5 6 
3. How confident are you in your ability to 
exercise regularly? 
(______Tick here if you have been advised 
NOT to exercise) 
0 1 2 3 4 5 6 
4. How confident are you in your ability to 
keep your weight under control? 
 
0 1 2 3 4 
 
5 
 
6 
5. How confident are you in your ability to 
keep your blood sugar level under control?  
 
0 1 2 3 4 
 
5 
 
6 
6. How confident are you in your ability to 
resist food temptations? 0 1 2 3 4 
 
5 
 
6 
7. How confident are you in your ability to 
follow your diabetes treatment (diet, 
medication, blood sugar testing, physical 
activities)? 
0 1 2 3 4 5 5 
8. To what extent do you think that 
following your diet is important for 
controlling your diabetes? 
0 1 2 3 4 
 
5 
 
6 
9. To what extent do you think that taking 
your medication as recommended (pills, 
insulin) is important for controlling your 
diabetes?  
(______ Tick here if you do NOT take 
medication for your diabetes). 
0 1 2 3 4 5 6 
10. To what extent do you think that 
exercise is important for controlling your 
diabetes? 
(______ Tick here if you have been advised 
NOT to exercise) 
0 1 2 3 4 5 6 
11. To what extent do you think that 
measuring your blood sugar is important for 
controlling your diabetes? 
(______Tick here if self-monitoring of blood 
sugar levels has NOT been recommended) 
0 1 2 3 4 5 6 
Not at all 
confident 
Very 
confident 
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12. To what extent do you think that 
following your diabetes treatment (diet, 
medication, blood sugar testing, exercise) is 
important for controlling your diabetes? 
0 1 2 3 4 5 6 
12. To what extent do you think that 
following your diabetes treatment (diet, 
medication, blood sugar testing, exercise) is 
important for delaying and/or preventing 
long-term diabetes complications (problems 
related to eyes, kidneys, heart or feet)? 
0 1 2 3 4 5 6 
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1. Your age: 
 
2. YOUR HEIGHT: 
 
3. YOUR WEIGHT: 
 
4. NUMBER OF CHILDREN: 
 
5. What type of work do/did you do? 
 
 
 
 
6. What is the highest level of qualification that you have? 
 
___________________________________________________________ 
 
 
8. Which of these groups do you consider yourself to belong to (please tick one): 
White British 
White Irish 
White Other 
Indian 
Pakistani  
 Black African 
Black 
Caribbean 
Black Other 
Chinese 
Other 
 
  
  
  
  
Bangladeshi 
 
  
 
 
Form 8 
 
DEMOGRAPHIC QUESTIONNAIRE 
 
Please answer the questions below: 
 
 
 
 
 
 
Please read the following information before you answer the questions: 
 
 
A: Instructions 
 
1. This questionnaire is divided into 5 sections, labelled Form 1-5. 
2. Please answer all of the questions in each section in the order they 
appear in the questionnaire. 
3. There are no ‘right’ or ‘wrong’ answers, so please answer the questions 
as honestly as you can. 
4. Please read the instructions at the beginning of each section and circle 
the response which you feel is the most relevant to you. 
5. Although some statements may seem similar to others, no two are 
exactly the same. 
6. Please take your time to read and understand the questions thoroughly.  
7. If there is anything you do not understand, please ask the researcher for 
help. 
 
 
B: Confidentiality 
 
1. Your name will not be put on the questionnaire. The researchers have 
given each questionnaire a code number, known only to them. 
2. All information stored on computer is compliant with the Data Protection 
Act. 
3. The information you provide in this questionnaire is confidential and will 
not be shared with anyone outside the research team unless required by 
law under the terms of the Children’s Act (1989). 
 
 
If you have any queries please contact: 
Isabela Caramlau on  
 
 
Questionnaire type: AD 
 
Date of receipt……………    Participant no……………. 
Mood States and Diabetes in Pregnancy 
1 
 
 
 
 
 
 
  
 Tick one 
Marital Status  
1. Single [   ] 
2. Married/cohabiting [   ] 
3. Separated [   ] 
4. Divorced [   ] 
5. Widowed [   ] 
6. Partnered [   ] 
 
 
 
Socioeconomic Status  
Low  [   ] 
Middle [   ] 
High  [   ] 
 
 
 
Self-esteem Yes No 
Do you feel good about yourself as a person? [   ] [   ] 
Do you feel worthwhile? [   ] [   ] 
Do you feel you have a number of good qualities as a 
person? 
[   ] [   ] 
 
 
 
Prenatal Depression Yes No 
1. Have you ever felt depressed during your 
pregnancy? 
[   ] [   ] 
If yes, when and how long have you been feeling this 
way? 
 
If yes, how mild or severe would you consider your 
depression? 
 
 
 
 
Prenatal Anxiety Yes No 
1. Have you ever felt anxious during your pregnancy? [   ] [   ] 
If yes, how long have you been feeling this way?  
 
 
  
Views on pregnancy Yes No 
Was the pregnancy planned? [   ] [   ] 
Is the pregnancy wanted? [   ] [   ] 
   
Form 1 
 
Please place a tick in the column that describes you best: 
 
 
2 
 
 
History of previous depression Yes No 
1. Before this pregnancy, have you ever been 
depressed? 
[   ] [   ] 
If yes, when did you experience this depression?   
If yes, have you been under a GP’s care for this past 
depression 
  
If yes, did the GP prescribe any medication for your 
depression? 
  
 
 
  
Social Support Yes No 
1. Do you feel you receive adequate support from 
your partner? 
[   ] [   ] 
2. Do you feel you receive adequate practical support 
from your partner? (e.g. help with household chores 
or babysitting) 
[   ] [   ] 
3. Do you feel you can rely on your partner when you 
need help? 
[   ] [   ] 
4. Do you feel you can confide in your partner? [   ] [   ] 
   
1. Do you feel you receive adequate support from 
your family? 
[   ] [   ] 
2. Do you feel you receive adequate practical support 
from your family? (e.g. help with household chores or 
babysitting) 
[   ] [   ] 
3. Do you feel you can rely on your family when you 
need help? 
[   ] [   ] 
4. Do you feel you can confide in your family? [   ] [   ] 
   
1. Do you feel you receive adequate support from 
your friends? 
[   ] [   ] 
2. Do you feel you receive adequate practical support 
from your friends? (e.g. help with household chores 
or babysitting) 
[   ] [   ] 
3. Do you feel you can rely on your friends when you 
need help? 
[   ] [   ] 
4. Do you feel you can confide in your friends? [   ] [   ] 
 
 
  
Marital Satisfaction Yes No 
1. Are you satisfied with your marriage (or living 
arrangements)? 
[   ] [   ] 
2. Are you currently experiencing any marital 
problems? 
[   ] [   ] 
3. Are things going well between you and your 
partner? 
[   ] [   ] 
3 
 
 
 
 
  
Life stress Yes  No 
1. Are you currently experiencing any stressful events 
in your life such as: 
  
• Financial problems [   ] [   ] 
• Marital problems [   ] [   ] 
• Death in the family [   ] [   ] 
• Serious illness in the family [   ] [   ] 
• Moving  [   ] [   ] 
• Unemployment  [   ] [   ] 
• Job change [   ] [   ] 
 
 
  
Child care stress Yes No 
1. Is your infant experiencing any health 
problems? 
[   ] [   ] 
2. Are you having problems with your baby 
feeding? 
[   ] [   ] 
3. Are you having problems with your baby 
sleeping? 
[   ] [   ] 
 
 
  
Infant temperament Yes No 
1. Would you consider your baby irritable or 
fussy? 
[   ] [   ] 
2. Does your baby cry a lot? [   ] [   ] 
3. Is your baby difficult to console or soothe? [   ] [   ] 
 
 
  
Maternity blues Yes No 
1. Did you experience a brief period of tearfulness 
and mood swings during the first week after 
delivery? 
[   ] [   ] 
 
 
 
 
 
 
 
 
 
 
 
4 
 
 
 
 
 
 Yes 
definitely 
Yes 
sometimes 
No, not 
much 
No, not  
at all 
1. I wake early and then 
sleep badly for the rest of the 
night. 
    
2. I get very frightened or 
have panic feelings for 
apparently no reason at all. 
 
    
3. I feel miserable and sad. 
 
    
4. I feel anxious when I go 
out of the house on my own. 
 
    
5. I have lost interest in 
things. 
 
    
6. I get palpitations, or 
sensations of ‘butterflies’ in 
my stomach or chest. 
    
7. I have a good appetite. 
 
    
8. I feel scared or frightened. 
 
    
9. I feel life is not worth 
living. 
 
    
10. I still enjoy the things I 
used to. 
 
    
11. I am restless and can’t 
keep still. 
 
    
12. I am more irritable than 
usual. 
    
13. I feel as if I have slowed 
down. 
    
14. Worrying thoughts 
constantly go through my 
mind. 
    
Form 2 
 
Please place a tick in the column that describes you best: 
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Over the last two weeks 
All of the 
time 
5 
Most of 
the time 
4 
More than 
half of the 
time 
3 
Less than 
half of the 
time 
2 
Some of 
the time 
1 
At no 
time 
0 
1. I have felt cheerful and 
in good spirits 
      
2. I have felt cam and 
relaxed 
      
3. I have felt active and 
vigorous 
      
4. I woke up feeling fresh 
and rested 
      
5. My daily life has been 
filled with things that 
interest me 
      
Form 3 
 
Please indicate for each of the five statements which is closest to how you have been 
feeling over the last two weeks. Notice that higher numbers mean better well-being. 
 
Example: If you have felt cheerful and in good spirits more than half of the time 
during the last two weeks, put a tick in the box with the number 3.  
 
6 
 
 
 
 
 
A. Have you been able to talk about your feelings and problems with at least one friend 
during the last month? 
 
1. I could always talk freely about my feelings 
2. I usually could talk about my feelings 
3. About half the time I felt able to talk about my feelings 
4. I usually was not able to talk about my feelings 
5. I was never able to talk about my feelings 
 
 
 
B. Have you been able to talk about your feelings and problems with at least one of 
your relatives in the last month? 
 
1. I could always talk freely about my feelings 
2. I usually could talk about my feelings 
3. About half the time I felt able to talk about my feelings 
4. I usually was not able to talk about my feelings 
5. I was never able to talk about my feelings 
 
 
 
C. Have you been able to talk about your feelings and problems with your spouse or 
partner in the last month? 
 
1. I could always talk freely about my feelings 
2. I usually could talk about my feelings 
3. About half the time I felt able to talk about my feelings 
4. I usually was not able to talk about my feelings 
5. I was never able to talk about my feelings 
 
 
 
 
 
 
 
 
 
 
Form 4 
 
For each question, please circle the number that best describes you: 
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1.  I have been able to laugh and see the 
funny side of things. 
□ As much as I always could 
□ Not quite so much now 
□ Definitely not 
□ Not at all 
 
 
2. I have looked forward with 
enjoyment to things. 
□ As much as I ever did 
□ Rather less than I used to 
□ Definitely less than I used to 
□ Hardly at all 
 
 
3.  I have felt scared or panicky for no   
very good reason. 
□ Yes, quite a lot 
□ Yes, sometimes 
□ No, not much 
□ No, not at all 
 
 
4. Things have been getting on top of 
me. 
□ Yes, most of the time I haven’t been 
able to cope at all 
□ Yes, sometimes I haven’t been 
coping as well as usual 
□ No, most of the time I have coped 
quite well 
□ No, I have been coping as well as 
ever 
 
5. I have been so unhappy that I have 
had difficulty sleeping. 
□ Yes, most of the time 
□ Yes, sometimes 
□ Not very often 
□ No, not at all 
 
 
 
6. I have blamed myself unnecessarily 
when things went wrong. 
□ Yes, most of the time 
□ Yes, some of the time 
□ Not very often 
□ No, never 
 
 
7. I have been anxious or worried for 
no good reason. 
□ No, not at all 
□ Hardly ever 
□ Yes, sometimes 
□ Yes, very often 
 
 
8. I have felt sad or miserable. 
□ Yes, most of the time 
□ Yes, quite often 
□ Not very often 
□ No, not at all 
 
 
 
9. I have been so unhappy that I have 
been crying. 
□ Yes, most of the time 
□ Yes, quite often 
□ Only occasionally 
□ No, never 
 
 
 
 
 
10. The thought of harming myself has 
occurred to me. 
□ Yes, quite often 
□ Sometimes 
□ Hardly ever 
□ Never 
Form 5 
 
Please tick and UNDERLINE the answer that comes closest to how you 
have felt IN THE PAST 7 DAYS, not just how you feel today. 
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Appendix 8 – Test of normality 
 
 
Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
baseline HADS total 
depression 
.105 37 .200* .963 37 .258 
baseline HADS total anxiety .125 37 .158 .950 37 .100 
baseline marital satisfaction .539 38 .000 .237 38 .000 
six weeks infant 
temperament 
.417 38 .000 .648 38 .000 
AD1 EPDS total score .145 38 .041 .898 38 .002 
deprivation index score .174 38 .005 .854 38 .000 
six weeks child care stress 
total score 
.362 38 .000 .711 38 .000 
baseline life stress .371 38 .000 .692 38 .000 
baseline social support .310 38 .000 .549 38 .000 
PAID total score .113 38 .200* .931 38 .021 
MDQ_interf .172 38 .006 .881 38 .001 
MDQ_sev .113 38 .200* .979 38 .677 
MDQ_socsup .151 38 .028 .927 38 .016 
 
 
 
 
 
  
Regression 
 
 
 
 
Descriptive Statistics 
 Mean Std. Deviation N 
squarerootEPDS 2.3170 .90043 38 
baseline HADS total depression 5.5333 3.12934 75 
baseline HADS total anxiety 5.6316 3.72681 76 
baseline life stress .7403 1.20746 77 
baseline social support 1.5714 3.04107 77 
six weeks child care stress total 
score 
.5526 .79517 38 
Reflect SQRT MDQ Social 
Support 
1.5309 .37441 38 
SQRT MDQ Interference Time1 .9722 .62836 38 
 
 Correlations 
 squarerootEPDS baseline HADS 
total depression 
baseline HADS 
total anxiety 
baseline life stress baseline social 
support 
six weeks child 
care stress total 
score 
Reflect SQRT 
MDQ Social 
Support 
SQRT MDQ 
Interference 
Time1 
Pearson Correlation 
squarerootEPDS 1.000 .419 .610 .242 .328 .444 -.349 -.428 
baseline HADS total depression .419 1.000 .610 .112 .315 .276 -.173 -.109 
baseline HADS total anxiety .610 .610 1.000 .138 .309 .246 -.084 -.317 
baseline life stress .242 .112 .138 1.000 .195 .211 -.011 .037 
baseline social support .328 .315 .309 .195 1.000 .220 -.285 -.159 
six weeks child care stress total 
score 
.444 .276 .246 .211 .220 1.000 -.002 .070 
Reflect SQRT MDQ Social 
Support 
-.349 -.173 -.084 -.011 -.285 -.002 1.000 .503 
SQRT MDQ Interference Time1 -.428 -.109 -.317 .037 -.159 .070 .503 1.000 
Sig. (1-tailed) 
squarerootEPDS . .005 .000 .071 .022 .003 .060 .027 
baseline HADS total depression .005 . .000 .169 .003 .049 .156 .263 
baseline HADS total anxiety .000 .000 . .117 .003 .071 .311 .028 
baseline life stress .071 .169 .117 . .045 .102 .474 .413 
baseline social support .022 .003 .003 .045 . .092 .041 .170 
six weeks child care stress total 
score 
.003 .049 .071 .102 .092 . .497 .382 
Reflect SQRT MDQ Social 
Support 
.060 .156 .311 .474 .041 .497 . .001 
SQRT MDQ Interference Time1 .027 .263 .028 .413 .170 .382 .001 . 
N 
squarerootEPDS 38 37 37 38 38 38 21 21 
baseline HADS total depression 37 75 75 75 75 37 36 36 
baseline HADS total anxiety 37 75 76 76 76 37 37 37 
baseline life stress 38 75 76 77 77 38 38 38 
baseline social support 38 75 76 77 77 38 38 38 
six weeks child care stress total 
score 
38 37 37 38 38 38 21 21 
Reflect SQRT MDQ Social 
Support 
21 36 37 38 38 21 38 38 
SQRT MDQ Interference Time1 21 36 37 38 38 21 38 38 
 
 Variables Entered/Removed
a
 
Model Variables Entered Variables 
Removed 
Method 
1 
baseline social 
support, baseline 
life stress, 
baseline HADS 
total anxiety, 
baseline HADS 
total depression
b
 
. Enter 
2 
six weeks child 
care stress total 
score
b
 
. Enter 
3 
Reflect SQRT 
MDQ Social 
Support, SQRT 
MDQ Interference 
Time1
b
 
. Enter 
a. Dependent Variable: squarerootEPDS 
b. All requested variables entered. 
 
 
Model Summary
d
 
Model R R Square Adjusted R Square Std. Error of the 
Estimate 
Change Statistics 
R Square Change F Change df1 df2 Sig. F Change 
1 .643
a
 .414 .267 .77098 .414 2.820 4 16 .060 
2 .694
b
 .482 .310 .74822 .069 1.988 1 15 .179 
3 .774
c
 .598 .382 .70770 .116 1.884 2 13 .191 
a. Predictors: (Constant), baseline social support, baseline life stress, baseline HADS total anxiety, baseline HADS total depression 
b. Predictors: (Constant), baseline social support, baseline life stress, baseline HADS total anxiety, baseline HADS total depression, six weeks child care stress total 
score 
c. Predictors: (Constant), baseline social support, baseline life stress, baseline HADS total anxiety, baseline HADS total depression, six weeks child care stress total 
score, Reflect SQRT MDQ Social Support, SQRT MDQ Interference Time1 
d. Dependent Variable: squarerootEPDS 
 
 ANOVA
a
 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 6.705 4 1.676 2.820 .060
b
 
Residual 9.510 16 .594   
Total 16.216 20    
2 
Regression 7.818 5 1.564 2.793 .056
c
 
Residual 8.398 15 .560   
Total 16.216 20    
3 
Regression 9.705 7 1.386 2.768 .054
d
 
Residual 6.511 13 .501   
Total 16.216 20    
a. Dependent Variable: squarerootEPDS 
b. Predictors: (Constant), baseline social support, baseline life stress, baseline HADS total anxiety, baseline 
HADS total depression 
c. Predictors: (Constant), baseline social support, baseline life stress, baseline HADS total anxiety, baseline 
HADS total depression, six weeks child care stress total score 
d. Predictors: (Constant), baseline social support, baseline life stress, baseline HADS total anxiety, baseline 
HADS total depression, six weeks child care stress total score, Reflect SQRT MDQ Social Support, SQRT 
MDQ Interference Time1 
 
 
 
 
  
Coefficients
a
 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. Correlations Collinearity Statistics 
B Std. Error Beta Zero-order Partial Part Tolerance VIF 
1 
(Constant) 1.397 .368  3.799 .002      
baseline HADS total depression .013 .071 .044 .180 .859 .419 .045 .034 .610 1.639 
baseline HADS total anxiety .127 .059 .525 2.142 .048 .610 .472 .410 .610 1.638 
baseline life stress .105 .146 .141 .717 .484 .242 .177 .137 .955 1.047 
baseline social support .037 .061 .125 .603 .555 .328 .149 .116 .857 1.167 
2 
(Constant) 1.370 .357  3.833 .002      
baseline HADS total depression -.001 .069 -.004 -.017 .987 .419 -.004 -.003 .598 1.673 
baseline HADS total anxiety .121 .058 .501 2.100 .053 .610 .477 .390 .607 1.647 
baseline life stress .072 .144 .096 .498 .625 .242 .128 .093 .930 1.076 
baseline social support .028 .060 .094 .468 .647 .328 .120 .087 .847 1.180 
six weeks child care stress total 
score 
.317 .225 .280 1.410 .179 .444 .342 .262 .874 1.144 
3 
(Constant) 2.512 .800  3.142 .008      
baseline HADS total depression -.002 .067 -.008 -.032 .975 .419 -.009 -.006 .566 1.767 
baseline HADS total anxiety .103 .060 .428 1.737 .106 .610 .434 .305 .509 1.965 
baseline life stress .088 .136 .119 .649 .528 .242 .177 .114 .924 1.082 
baseline social support .003 .059 .011 .057 .955 .328 .016 .010 .787 1.270 
six weeks child care stress total 
score 
.371 .215 .328 1.724 .108 .444 .431 .303 .855 1.169 
Reflect SQRT MDQ Social 
Support 
-.482 .523 -.200 -.923 .373 -.349 -.248 -.162 .654 1.529 
SQRT MDQ Interference Time1 -.311 .319 -.217 -.975 .347 -.428 -.261 -.171 .621 1.609 
a. Dependent Variable: squarerootEPDS 
 
 Excluded Variables
a
 
Model Beta In t Sig. Partial Correlation Collinearity Statistics 
Tolerance VIF Minimum 
Tolerance 
1 
six weeks child care stress total 
score 
.280
b
 1.410 .179 .342 .874 1.144 .598 
Reflect SQRT MDQ Social 
Support 
-.288
b
 -1.484 .158 -.358 .904 1.106 .602 
SQRT MDQ Interference Time1 -.277
b
 -1.389 .185 -.338 .873 1.146 .552 
2 
Reflect SQRT MDQ Social 
Support 
-.311
c
 -1.681 .115 -.410 .899 1.112 .588 
SQRT MDQ Interference Time1 -.325
c
 -1.717 .108 -.417 .854 1.171 .544 
a. Dependent Variable: squarerootEPDS 
b. Predictors in the Model: (Constant), baseline social support, baseline life stress, baseline HADS total anxiety, baseline HADS total depression 
c. Predictors in the Model: (Constant), baseline social support, baseline life stress, baseline HADS total anxiety, baseline HADS total depression, six weeks 
child care stress total score 
 
 Collinearity Diagnostics
a
 
Model Dimension Eigenvalue Condition Index Variance Proportions 
(Constant) baseline HADS 
total depression 
baseline HADS 
total anxiety 
baseline life stress baseline social 
support 
six weeks child 
care stress total 
score 
Reflect SQRT 
MDQ Social 
Support 
SQRT MDQ 
Interference 
Time1 
1 
1 3.504 1.000 .01 .01 .01 .03 .03    
2 .633 2.353 .04 .02 .02 .30 .48    
3 .612 2.394 .00 .00 .00 .65 .44    
4 .155 4.750 .75 .01 .48 .01 .05    
5 .096 6.031 .20 .96 .48 .00 .01    
2 
1 3.993 1.000 .01 .01 .01 .02 .02 .02   
2 .633 2.512 .04 .02 .02 .30 .47 .00   
3 .614 2.551 .00 .00 .00 .58 .46 .02   
4 .510 2.799 .02 .01 .01 .08 .00 .96   
5 .155 5.072 .73 .01 .49 .01 .05 .00   
6 .096 6.451 .20 .95 .47 .01 .01 .00   
3 
1 5.432 1.000 .00 .00 .00 .01 .01 .01 .00 .00 
2 .849 2.530 .00 .00 .00 .07 .39 .04 .00 .03 
3 .619 2.963 .00 .01 .01 .80 .14 .01 .00 .00 
4 .521 3.229 .00 .00 .00 .10 .09 .89 .00 .00 
5 .360 3.886 .00 .04 .14 .02 .31 .01 .00 .16 
6 .117 6.825 .04 .56 .04 .00 .02 .02 .05 .23 
7 .084 8.056 .08 .27 .76 .00 .00 .01 .01 .43 
8 .019 16.768 .87 .12 .04 .00 .05 .00 .93 .14 
a. Dependent Variable: squarerootEPDS 
 
  
Residuals Statistics
a
 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 1.2884 3.6675 2.5085 .62510 20 
Std. Predicted Value -1.477 1.939 .275 .897 20 
Standard Error of Predicted 
Value 
.214 .635 .412 .122 20 
Adjusted Predicted Value 1.0739 4.5064 2.5181 .85242 20 
Residual -1.49396 .90535 -.00906 .63465 20 
Std. Residual -2.111 1.279 -.013 .897 20 
Stud. Residual -3.037 2.348 -.026 1.246 20 
Deleted Residual -3.09215 3.04917 -.01862 1.29583 20 
Stud. Deleted Residual -5.414 2.972 -.130 1.680 20 
Mahal. Distance .871 15.139 6.403 4.141 20 
Cook's Distance .004 1.631 .214 .442 20 
Centered Leverage Value .044 .757 .320 .207 20 
a. Dependent Variable: squarerootEPDS 
 
 
 
Charts 
 
 
 
 
 
